Legal status in Austria

Per-substance legal status for Austria, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

83 confirmed substances5 not individually verifiedLast updated October 3, 2026

Confirmed legal status

1P-LSD

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 11 of the NPS regulation's structural annexes: the official structural illustrations to the new psychoactive substances regulation name 1-Propionyl-Lysergsäurediethylamid, 1P-LSD. Its N1 propionyl substitution fits the ergoline carboxamide core in group 11 of Annex II, and the named illustration is evidence of that fit rather than a listing carrying operative words of its own. The Act's own requirements still have to be met: synthetic manufacture under NPSG §1, the medicinal channel exclusion in NPSG §2, and the conduct and intent elements of §4. NPSG §3(2) authorises the Minister to define chemical substance classes where that is better suited than naming individual substances, and NPSV §1(1) includes both Annex I's named substances and every substance encompassed by Annex II's chemical definitions, with §1(2) enumerating the permitted substituent structures and Annex III illustrating rather than exhausting the groups. A structural overlap does not create simultaneous narcotics and NPS liability: the Suchtmittelgesetz is applied first and this regime only reaches what the SMG does not.
Consequences if caught: Capital exposure: none. The Austrian NPS Act tops out at ten years under NPSG §4(2), and only where the §4(1) offence has caused a death or serious injuries to a larger number of people. No life term sits above that, and the death penalty does not exist in Austria. 1P-LSD is an NPS and not a narcotic, so it carries a very much lower ceiling than the LSD it is a prodrug of. The base offence in NPSG §4(1) allows two years, and it is emphatically not a possession offence: it requires an intention to obtain an advantage, the production, import, export, transfer or procurement conduct, and the intent that the other person or a third party use the substance to achieve a psychoactive effect in the human body. Mere possession is absent from it. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. The practical point is the one the ceiling turns on: 1P-LSD is answered by the NPS instrument while the LSD it relates to is a named narcotic, so the two are not interchangeable at a border any more than they are in the annexes.
Documentation: Carry nothing under a prescription heading for this, because the material read establishes no Austrian medicinal authorisation and the NPS regime has no dispensing channel of its own. 1P-LSD and LSD sit in different instruments with different ceilings, so do not read the LSD row across to it. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 11 with the Annex III ergoline illustration naming 1-Propionyl-Lysergsäurediethylamid, 1P-LSD, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: Annex III was read to its end at page 9, where the ergoline illustrations and the official signature close it, so that nothing beyond the illustrated examples was assumed · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

1P-LSD in Austria, full detail →

2-FDCK

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex IV.1 prints the systematic name 2-Fluorodeschloroketamin beside the trade abbreviation 2-FDCK. Nothing in that pairing narrows the listing to one salt or one form. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. 2-FDCK is reached as a named Annex IV.1 narcotic, so the Suchtgift ladder and not the psychotrope ladder measures it. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. What the source establishes for 2-FDCK is the Annex IV.1 designation and no medicinal product, so the medical limb of that rule is not shown to be open to it and the scientific limb would run on its own licence.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. There is no lawful Austrian 2-FDCK prescription to document. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry 2-Fluorodeschloroketamin, 2-FDCK, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex IV.1 was read to its end at page 32 of the consolidated PDF, including the closing salts, esters, ethers and preparations clauses and the footnote excluding butyrolactone · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

2-FDCK in Austria, full detail →

25I-NBOMe

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex V.1 carries it under both of its common names, 25I-NBOMe and 2C-I-NBOMe. The second name is the one that ties it to the 2C-I entry held in a different part of the annex set. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Because 25I-NBOMe sits in Annex V.1 rather than in the psychotrope list, the whole SMG narcotics ladder is what applies to it. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The route recorded for 25I-NBOMe reaches its Annex V.1 designation and stops there, establishing no Austrian medicinal product, so nothing here shows a dispensed supply that could satisfy the medical limb.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. No prescription route exists for 25I-NBOMe in any of the instruments read. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry 25I-NBOMe, 2C-I-NBOMe, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the Annex V.2 entry for the 2C compound whose name is carried inside this one was read alongside it, the two annexes closing with different extension language · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

25I-NBOMe in Austria, full detail →

2C-B

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex V.1 carries the three characters 2C-B and nothing else. Austria did not write the systematic phenethylamine name into the entry, and it did not need to. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. 2C-B is an Annex V.1 narcotic, which puts it on the SMG narcotics ladder rather than on the NPS route its structure might otherwise suggest. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. For 2C-B the source establishes the Annex V.1 designation alone. No Austrian medicinal product for it is established here, so a dispensed route cannot be asserted to anyone.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. 2C-B cannot be prescribed in Austria, so there is no document to carry for it. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry 2C-B, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex V was read to its end at page 34, where its own preparations clause closes the list, and the two V.2 placements of the neighbouring 2C compounds were compared with this V.1 placement · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

2C-B in Austria, full detail →

2C-E

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 2 of the NPS regulation's structural annexes: 2C-E is not named in any list; it is reached because Annex II group 2 covers any compound derivable from a phenethylamine base structure. 2C-E retains that core with 2,5-methoxy and 4-ethyl substituents. It is not expressly named in the Suchtgiftverordnung or the Psychotropenverordnung, which is what leaves the generic route to answer it, and that is a structural interpretation rather than a named listing. The new psychoactive substances regime works by generic definition. NPSG §3(2) permits chemical substance classes to be defined, NPSV §1(1) takes in Annex I by name and Annex II by structure, and Annex III's illustrations are examples rather than an exhaustive set. NPSG §1 requires psychoactivity and synthetic manufacture, and §2 removes lawful medicinal channels and SMG controlled substances from scope, so the structural fit is necessary and not sufficient.
Consequences if caught: Capital exposure: none. The maximum here is ten years under NPSG §4(2), for a §4(1) offence resulting in death or serious injuries to a larger number of people. The life ceiling in SMG §28a(5) belongs to the narcotics instrument, and capital punishment to no part of Austrian law. 2C-E is reached by a generic structural definition rather than by name, so the prosecution has to establish the derivation before any tier applies at all. NPSG §4(1) carries two years and three separate elements: the advantage intent, the specified supply conduct, and the intent that another use the substance for psychoactive effect. Possession alone satisfies none of them, although NPSG §5 still permits confiscation without prosecuting any particular person. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. The contrast that matters here is with its own siblings: 2C-B, 2C-I and 2C-T-7 are named narcotics governed by the authorized purpose rule, while 2C-E is reached by structure and sits outside that list entirely.
Documentation: Carry no assumption that an absent name means an unregulated substance, because the NPS annexes work by chemical definition as well as by list and Annex III's illustrations do not exhaust the groups. 2C-E is caught structurally while its close relatives 2C-B, 2C-I and 2C-T-7 are named narcotics, so the four are not interchangeable. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 2, the phenethylamine base structure definition, applied to 2C-E, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: the narcotics and psychotrope lists were both searched for an express entry and returned nothing, which is what leaves the generic definition to answer the row · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

2C-E in Austria, full detail →

2C-I

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. In the Suchtgiftverordnung, Annex V.2 carries 2C-I as a bare entry. Its placement in V.2 rather than V.1 matters, because each of those two lists closes with its own extension wording. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. The V.2 placement of 2C-I keeps it inside the Suchtgift offences, where the ladder starts at SMG §27 and ends at §28a(5). Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The material read for 2C-I establishes its Annex V.2 designation and nothing about a medicinal product, so the medical limb of the authorized purpose rule is not shown to be available to it.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. No Austrian prescriber can issue 2C-I, so nothing medical exists to show. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.2, the entry 2C-I, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: both V.1 and V.2 were read in full so that the split of the 2C compounds between the two lists could be seen rather than assumed · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

2C-I in Austria, full detail →

2C-T-7

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex V.2 names 2C-T-7 without qualification. The sulfur bearing side chain that distinguishes it from the other 2C compounds is not written into the entry, and the entry does not need it. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. 2C-T-7 sits with the Annex V.2 narcotics, so its exposure is the Suchtgift scale in full. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. 2C-T-7's row establishes a designation and not a dispensing channel, so the limb realistically in question is the scientific one, and that runs on a licence rather than on a prescription.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. 2C-T-7 has no dispensing route in Austria at all. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.2, the entry 2C-T-7, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex V.2 was read to its end and its closing clauses compared with V.1's, because the sulfur bearing and halogenated 2C compounds are distributed across both · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

2C-T-7 in Austria, full detail →

3-MMC

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex V.2 prints the systematic 3-Methyl-Methcathinon together with the abbreviation 3-MMC. The entry places the ring methyl at the 3 position expressly, which is what separates it from the 4-methyl cathinone held elsewhere in the same annex. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. 3-MMC is an Annex V.2 narcotic, so the cathinone it resembles and it share the same ladder. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. 3-MMC's designation is what the source establishes, and it establishes no medicinal product, so the medical limb is not shown to be open and the scientific limb operates under its own licensing.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. 3-MMC is not dispensable on any Austrian prescription. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.2, the entry 3-Methyl-Methcathinon, 3-MMC, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the 4-methyl cathinone entry in the same annex and the parent cathinone entry in V.1 were read at the same time, which is what fixes the ring position as the distinguishing feature · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

3-MMC in Austria, full detail →

4-AcO-DMT

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. 4-AcO-DMT is not named at all; it is reached because Annex V.1 lists psilocin and psilotin and then extends that list to the esters, ethers and molecular compounds of the narcotics named under V.1. 4-AcO-DMT is the O-acetyl ester of psilocin, so the express ester limb catches it without any analogue reasoning. The SMG takes priority over the NPS regime, so this is a narcotics question and not a new psychoactive substance question. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. Because 4-AcO-DMT arrives through the V.1 ester extension rather than through a name, the prosecution has to make out that ester relationship, but once made out the Suchtgift ladder applies unchanged. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The ester extension that reaches 4-AcO-DMT carries no medical limb of its own and no Austrian medicinal product for it is established, so its position under the authorized purpose rule follows psilocin's rather than standing separately.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. There is no prescribable 4-AcO-DMT product, and its control is derivative of psilocin. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the psilocin and psilotin entries read with the ester, ether and molecular compound extension, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the psilocin and psilotin entries were read together with the V.1 clause on esters, ethers and molecular compounds, since the placement rests on that clause and not on any entry · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

4-AcO-DMT in Austria, full detail →

4-HO-MET

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 6 of the NPS regulation's structural annexes: 4-HO-MET is not named; Annex II group 6 covers tryptamine and any compound derivable from that base structure, including one bearing the substituents permitted by NPSV §1(2). 4-HO-MET keeps the tryptamine core with a 4-hydroxy group and N-methyl and N-ethyl substituents, which fits group 6 for synthetic material. The dossier is careful on the boundary with the narcotics list: the extra N-ethyl carbon prevents treating it as a positional isomer of the listed psilocin, so the SV §1(5) isomer rule does not reach it. Austria regulates new psychoactive substances by structure rather than by list alone. NPSG §1 additionally requires psychoactivity and synthetic manufacture, and §2 excludes lawful medicinal channels and anything already subject to the Suchtmittelgesetz, so the SMG is applied first and the NPS scope second. The twelve cannabinomimetic cores and the other group definitions are alternatives rather than a catch all, and the annex has to be read as written rather than as a general ban on novel compounds.
Consequences if caught: Capital exposure: none. NPSG §4(2) sets one to ten years where the §4(1) offence causes death or serious injury to a larger number of people, and that is the whole of the ceiling, with no life term and no capital sentence behind it. 4-HO-MET is an NPS rather than a psilocin isomer, and that distinction is what keeps it off the narcotics ladder. Two years is the base figure under NPSG §4(1), and the shorthand that an NPS ban makes possession an offence is simply not the offence Austria wrote. Section 5 nonetheless permits confiscation unless the lawful purpose exception is met, and §7 supplies customs seizure powers. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. 4-HO-MET has no medicinal listing in Austria, so no dispensed product of it can exist.
Documentation: Carry a written record of what the substance actually is, because the instrument that applies and the ceiling that follows both depend on the structural identification rather than on the name it was sold under. 4-HO-MET is not treated as a psilocin isomer, which is the finding that decides its instrument. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 6, the tryptamine base structure definition read with NPSV §1(2), applied to 4-HO-MET, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: the psilocin entry in the narcotics instrument was read against this structure, and the extra carbon on the amino nitrogen is what prevents the isomer rule from reaching it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

4-HO-MET in Austria, full detail →

6-APB

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 2 of the NPS regulation's structural annexes: 6-APB is reached through Annex II group 2's phenethylamine base structure together with the expressly permitted benzofuran and dihydrobenzofuran ring replacements. The benzofuran ring standing in for the phenyl ring is written into the permitted structures, and 6-APB carries the alpha-methyl substituent as well. The Act's scope and intent conditions still apply on top of the structural fit. NPSG §3(2) authorises the Minister to define chemical substance classes where that is better suited than naming individual substances, and NPSV §1(1) includes both Annex I's named substances and every substance encompassed by Annex II's chemical definitions, with §1(2) enumerating the permitted substituent structures and Annex III illustrating rather than exhausting the groups. A structural overlap does not create simultaneous narcotics and NPS liability: the Suchtmittelgesetz is applied first and this regime only reaches what the SMG does not.
Consequences if caught: Capital exposure: none. The ceiling is the one to ten years in NPSG §4(2), reached through the aggravated consequence limb of the §4(1) offence, in a system that has abolished the death penalty and attaches no life term to this Act. 6-APB is on the NPS route because its ring replacement is expressly permitted, not because of any general analogue reasoning. The §4(1) offence sits at two years and reaches supply rather than holding. Section 4 specifies imprisonment with no cumulative fine, which is a different structure from the narcotics and psychotrope offences. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. 6-APB's benzofuran ring replacement is expressly permitted by the structural definitions, so its coverage does not rest on an argument about resemblance that a carrier could contest.
Documentation: Carry no prescription for this, because none is established anywhere in the material read: NPSG §2 only removes channels that already exist elsewhere. The benzofuran substitution is expressly named in the Austrian structural definitions, so 6-APB is not an unlisted compound. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 2 with the expressly permitted benzofuran and dihydrobenzofuran ring replacements, applied to 6-APB, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: the enumerated permitted ring replacements in NPSV §1(2) were read in full, the benzofuran and dihydrobenzofuran replacements being named there expressly · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

6-APB in Austria, full detail →

Adderall

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. The brand name is absent from every instrument read; what is present in Annex IV.1 is Amphetamin and Dexamphetamin, together with the clauses extending IV.1 to the salts and to all preparations of the narcotics listed there. Adderall is a mixture of amphetamine and dextroamphetamine salts, so the named constituents, the salts clause and the preparations clause reach it three times over. A product does not escape the narcotics list by being sold under a trade name. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Adderall is prosecuted as its constituents, so the amount that matters is the pure amphetamine and dextroamphetamine content and not the tablet weight. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Adderall is the clearest case for the authorized purpose rule: a genuine dispensed narcotic medicine is inside SMG §5(1), and an imported stimulant supply without that standing is not.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. Name the active substances and not only the brand, because the Austrian entries are Amphetamin and Dexamphetamin. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entries Amphetamin and Dexamphetamin with the salts and preparations clauses, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the salts clause and the all preparations clause closing Annex IV.1 were read in full, because a branded mixture is reached through them rather than through an entry of its own · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Adderall in Austria, full detail →

Alcohol

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. Beverage alcohol sits outside the narcotics, psychotrope and NPS designations entirely; the federal trade act §114 forbids a trader from serving or supplying alcoholic drinks to young people where the applicable Land's youth protection rules prohibit them from drinking at that age. The federal provision expressly points at the Land rules rather than setting an age itself, so the operative age limit is provincial. Food law applies to the product in the ordinary way.
Consequences if caught: Capital exposure: none. The obligations here come from food, product or trade law, because no narcotics or psychotrope designation exists, so no SMG tier and no life ceiling attaches. Austria has no death penalty in any case. Alcohol carries no SMG exposure whatever, and its enforcement runs through trade and youth protection rules rather than through any drug ladder. Enforcement therefore runs through the authority that polices that instrument rather than through a drug prosecution, and the offence elements are the instrument's own. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Alcohol is not a Suchtmittel, so the whole authorized purpose structure in SMG §5(1) is irrelevant to it and no medical document is needed to carry it.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. The operative drinking age is set by the Land and not by the federal provision, which only points to it. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the trade act provision read at https://www.ris.bka.gv.at/NormDokument.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10007517&Paragraf=114, the federal trade act §114 on serving alcoholic drinks to young people, read with the applicable Land youth protection rules · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the federal provision was read as one that points to the provincial youth protection rules rather than setting an age, and the nine provincial regimes were not individually audited · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Alcohol in Austria, full detail →

Amanita muscaria

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. The fly agaric is not designated in the narcotics or psychotrope lists, it is outside the NPS Act because that Act defines a substance as a synthetically manufactured chemical compound, and food law prohibits placing unsafe food on the market. Its isoxazole constituents were checked against the NPS structural groups and miss the phenyl oxazole core in group 10, so the structural route does not reach them either. Sale as food remains subject to the safety obligation.
Consequences if caught: Capital exposure: none. Austria reaches this row through product and consumer law rather than through the drug instruments, so the SMG ladder never starts and its life ceiling in §28a(5) has nothing to attach to, in a country that executes nobody. Amanita muscaria carries no SMG tier, and what restrains its sale is food safety law rather than any drug offence. The penalties belong to the instrument that applies, are set by it rather than by the SMG, and bind the seller at least as often as the person holding the product. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Amanita muscaria is not a Suchtmittel and has no prescription route, so neither the authorized purpose rule nor the psychotrope medicine exception has anything to say about it.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. The mushroom's constituents were checked against the NPS cores and miss them, so its position rests on food law. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the absence of any narcotics or psychotrope entry, the NPSG synthetic manufacture definition, and the general food law prohibition on unsafe food · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the general food law was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32002R0178 · at that placement the reading also covered this: the isoxazole constituents were checked against the NPS group defined by a phenyl oxazole core and miss it, and the synthetic manufacture requirement was read in the Act itself · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Amanita muscaria in Austria, full detail →

Amphetamine

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex IV.1 carries the single German word Amphetamin. The salts clause and the preparations clause that close IV.1 then carry that single word into every salt and every preparation of it. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. Amphetamine is an Annex IV.1 narcotic, and SMG §28b requires its threshold to be calculated on the pure active substance, so cutting agents do not raise the figure. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Where a dispensed amphetamine narcotic medicine exists it is inside the authorized purpose rule and loose powder never is, but what this source establishes is the Annex IV.1 designation and not that any particular Austrian product is authorised.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. An amphetamine medicine is a narcotic medicine in Austria, not an ordinary one. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Amphetamin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex IV.1 was read from its first entry to its closing extension clauses at page 32, and the separately listed dextroamphetamine entry was noted in the same pass · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Amphetamine in Austria, full detail →

Amyl Nitrite

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: amyl nitrite appears in part 2 of Annex A to the prescription regulation marked RP, and the general product safety regulation requires economic operators to place only safe products on the market. As a medicine it is prescription only. The official poppers notice records that the former automatic functional medicine classification no longer follows the 2014 Court of Justice interpretation, so a recreational formulation is not automatically a medicine, although a medicinal presentation can still bring a product under the medicines act. Isopropyl and cyclohexyl nitrites do not inherit the amyl nitrite listing. A prescription entry applies to medicines and not automatically to every use of a raw chemical. AMG §7 sets the authorisation requirements with their exceptions, and §59 provides that medicines may be supplied only through pharmacies except where §§57 and 58 or the following provisions say otherwise.
Consequences if caught: Capital exposure: none. The exposure here is a medicines exposure, because neither the narcotics nor the psychotrope instrument designates this substance, so no SMG tier ever starts and no life term is available. Austria has no death penalty either. Amyl nitrite is the only nitrite with an Austrian medicine listing, and no narcotics or NPS tier reaches it. The figures are fact specific. AMG §84(1) reaches EUR 25,000, or EUR 50,000 on repeat, for the offences it lists, while the separate §83(1) dispensing breaches reach EUR 7,500, or EUR 14,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Amyl nitrite exists as a prescription medicine, so a dispensed medicinal product is the lawful form and a recreational bottle is a product law question instead.
Documentation: Carry the labelled pack and the prescription that produced it, since the whole of the Austrian control here is a prescription requirement. Amyl nitrite has a medicine listing that isopropyl and cyclohexyl nitrites do not share. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the amyl nitrite entry marked RP, with the general product safety regulation, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · the general product safety regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32023R0988 · the official poppers interpretation was read at https://www.basg.gv.at/marktbeobachtung/amtliche-nachrichten/detail/poppers · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the official interpretation was read in full alongside the medicine entry, and the other alkyl nitrites were checked separately and do not share the listing · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «Amylnitrit» carrying the status code RP, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, prescription required. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Amyl Nitrite in Austria, full detail →

Ayahuasca

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. The brew has no entry of its own; Annex V.1 lists DMT and extends itself to all preparations of the narcotics named in that annex. A brew containing DMT is therefore a controlled preparation whatever it is called, ritually or on the street. Harmine and harmaline were searched separately and neither of them removes the DMT control. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. Ayahuasca is measured as a DMT preparation, and since SMG §28b fixes the threshold on the pure active substance, the litres of liquid are not the figure that counts. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal or religious dispensing route for ayahuasca appears in any instrument read, so the authorized purpose rule offers it nothing.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. A ceremonial or religious context is not one of the four authorized purposes in SMG §5(1). The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the DMT entry read with the clause covering all preparations of the narcotics in that annex, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the harmine and harmaline searches were run separately against all three drug instruments and returned nothing that displaces the named constituent's control · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Ayahuasca in Austria, full detail →

Barbiturates

Legal status: Controlled in Austria member by member, and Austria's own instruments name the members, so this is a finding rather than a deferral. No barbiturate has a row of its own among the 88 substances in this table, but a list that names individuals is not silent merely because the table is. The examined schedules carry no blanket barbiturate clause, so the class word has no status of its own and each molecule is placed by its printed name. Secobarbital is a Suchtgift, a narcotic in the statutory sense, in Annex IV.1 of the Suchtgiftverordnung. Eleven further members are psychotropic substances in Annex 1 of the Psychotropenverordnung: amobarbital, butalbital, cyclobarbital and pentobarbital at point 1, and allobarbital, barbital, butobarbital, methylphenobarbital, phenobarbital, secbutabarbital and vinylbital at point 2. Barbital carries its own carve out for qualifying diagnostic or analytical packs that contain no other controlled substance and no more than 20 g calculated as acid, and pentobarbital also appears on the veterinary prescription list. Methohexital and thiopental sit in neither list and are controlled as medicines only, in part 2 of Annex A to the Rezeptpflichtverordnung, marked NR so that repeat dispensing is not allowed. The Suchtgiftverordnung extends Annex IV.1 to the salts, esters, ethers and preparations of what it names, while the Psychotropenverordnung extends its names to their salts and preparations and has no derivative or isomer clause. A barbiturate that is not printed under its own name does not become a Suchtgift or a psychotrope by being called a barbiturate, this cell gives no answer for such a molecule, and nothing in the member mapping supplies a market authorisation for an unnamed product. Identify the specific substance first, because the placement, and with it the penalty, differs between the named members.
Consequences if caught: Capital exposure: none. Austrian law carries no death penalty, and the ceiling here splits by member rather than by class. Secobarbital is a Suchtgift and meets the full narcotics ladder. SMG §27(1) reaches unauthorised acquisition, possession, production, carriage, import, export, offering, transfer or procurement with up to one year or 360 day fines, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. Above the Grenzmenge, the threshold quantity that SMG §28b fixes on the pure active substance, §28(1) possession with intent to put it into circulation carries up to three years, and §28a(1) production, import, export or supply carries up to five years, rising to one to fifteen years in the §28a(4) cases. SMG §28a(5) then provides ten to twenty years or life for a person who commits §28a(1) conduct while leading a larger connection of people. The eleven Psychotropenverordnung members meet the psychotrope ladder instead. SMG §30(1) provides up to one year or 360 day fines and §30(2) six months or 360 day fines for exclusively personal use, and §30(3) removes punishment under those two subsections for a medicine containing a psychotropic substance, not exceeding the threshold, acquired, possessed, carried, imported or exported for personal use or for an animal, or passed to another without advantage. Above the threshold, §31 preparation with circulation intent runs from up to two years to one to ten years for association membership under §31(3), and §31a trafficking from up to three years to one to ten years under §31a(3), so ten years is the ceiling for every psychotrope member. SMG §35(1) requires the prosecution, on the conditions set in §35(3) to (7), to step back provisionally for a probation period of one to two years from a §27(1) or (2) or a §30 offence committed exclusively for personal use without advantage, which is conditional diversion and not permission. Methohexital and thiopental carry no SMG tier at all. The medicines act has its own offence lists, and AMG §84(1) reaches EUR 25,000, or EUR 50,000 on repeat, for the offences it lists; that is not an automatic fine for holding a prescription medicine, and the applicable medicine offence depends on the conduct. So one seizure described as barbiturates can sit at three different ceilings, and the identified molecule decides which. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They are recorded as Austria's published drug penalties and not as this row's exposure. Where they differ from the offence sections set out above, those sections govern: for secobarbital §28a(4) is one to fifteen years and §28a(5) is ten to twenty years or life, and the psychotrope members are governed by sections 30 to 31a.
If prescribed / medical: Austria's traveller rule is SMG §5(1) and it applies to every member of this class that is a Suchtmittel: such a substance may be acquired, possessed, carried, imported or exported only for medical, dental, veterinary or scientific purposes and only as the Act provides, with the travel, licensing and dispensing exemptions each governed by their own provisions. The branch then follows the member. Secobarbital is a narcotic, so the psychotrope non punishment route in SMG §30(3) is closed to it. The eleven Psychotropenverordnung members are psychotropes, so §30(3) is open to a medicine containing one of them on its stated conditions, and the travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung are the documented route for them. Methohexital and thiopental are not Suchtmittel on the lists read; they are prescription only medicines under part 2 of Annex A to the Rezeptpflichtverordnung with repeat dispensing excluded, and AMG §59 confines the supply of medicines to pharmacies except where the Act provides otherwise. Never answer this row at class level for a patient: name the molecule on the label first.
Documentation: Carry documentation that names the specific barbiturate, because the class label decides nothing in Austria and the three possible branches are a narcotic, a psychotrope and an ordinary prescription medicine. Bring the dispensed pack, the prescription and a prescriber's letter giving patient, active substance, dose and treatment period, and for a psychotrope member raise the Psychotropenverordnung travel certificate with the prescriber. The narcotics placement was read at the 18 September 2026 consolidation whose last list amendment is BGBl II 180/2026, published 10 July 2026, the psychotrope placements at the consolidation whose last list amendment is BGBl II 394/2024, published 19 December 2024, and the prescription entries at the consolidation listing BGBl II 282/2025. Those are dated source horizons rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1 for secobarbital, Psychotropenverordnung Annex 1 points 1 and 2 for the eleven named members, and Annex A part 2 of the Rezeptpflichtverordnung for methohexital and thiopental · the narcotics instrument read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the psychotrope instrument at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the prescription regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the designation powers are Suchtmittelgesetz §§2 and 3 and the offences §§27 to 28a, §§30 to 31a and §35, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · the medicines act, §59 and §84(1), at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · the list amendments applied are BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 and BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · read as at 18 September 2026 · this site's published Austria entry, citing the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung, for the carried paragraph on sections 27, 28, 28a and 35 · Updated October 3, 2026

Barbiturates in Austria, full detail →

Benzodiazepines

Legal status: Controlled member by member in Austria as psychotropic substances, and the class label is not itself a status. Flunitrazepam sits alone in Psychotropenverordnung Annex 1 point 1 and requires the special narcotic prescription form under PV §10(3); that form requirement does not move it into the narcotics instrument. Every other named member sits in Annex 1 point 2, and the instrument names them one at a time: alprazolam, bromazepam, bromazolam, brotizolam, camazepam, chlordiazepoxide, clobazam, clonazepam, clonazolam, clorazepate, clotiazepam, cloxazolam, delorazepam, diazepam, diclazepam, estazolam, ethyl loflazepate, etizolam, flualprazolam, flubromazolam, fludiazepam, flurazepam, halazepam, haloxazolam, ketazolam, loprazolam, lorazepam, lormetazepam, medazepam, midazolam, nimetazepam, nitrazepam, nordazepam, oxazepam, oxazolam, phenazepam, pinazepam, prazepam, temazepam, tetrazepam and triazolam. Six of those members carry their own rows in this table: diazepam, alprazolam, clonazepam, lorazepam, etizolam and nimetazepam, and each of them resolves to Annex 1 point 2. The prescription regulation separately covers benzodiazepine medicines as a class, marked for no repeat dispensing, in both the human and veterinary lists, but an unlisted designer member does not acquire psychotrope status from that medical classification. Zolpidem has its own entry and is not classified here as a benzodiazepine. So the class label covers a prescribing category, while the schedule carries individual names, and the two are not the same set.
Consequences if caught: Capital exposure: none. The ceiling for every member of this class is ten years, under SMG §31(3) for preparation above the threshold as a member of a criminal association and SMG §31a(3) for trafficking in that form. The life ceiling in SMG §28a(5) belongs to the narcotics instrument, which holds no benzodiazepine at all. Below that, §30(1) reaches one year or 360 day fines for unauthorized acquisition, possession, carriage, import, export or supply, §30(2) reaches six months for exclusively personal use, §31(1) and §31(2) reach two and five years for preparation, and §31a(1) and §31a(2) reach three and five years for trafficking. Flunitrazepam's special prescription form under PV §10(3) is a prescribing control and adds nothing to those figures. SMG §31b requires the threshold to be taken on the pure active substance, which matters for tablets of very different strengths. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is SMG §5(1), and for this class the important second provision is SMG §30(3). That subsection removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without advantage. Every member of this class that is an authorised medicine is inside that wording, which is why a dispensed benzodiazepine course is an ordinary medical item in Austria and not a dangerous drug. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, and that certificate is the documented route. Two qualifications matter. Flunitrazepam needs the special narcotic prescription form under PV §10(3), so its paperwork is heavier than the rest. A designer member bought as a research chemical is not a medicine, so §30(3) does not reach it however closely it resembles a prescribed one.
Documentation: Carry the dispensed pack and the prescription naming the patient, the active substance, the strength and the treatment period, and obtain the psychotrope travel certificate whose fields close Annexes 2 and 3 of the Psychotropenverordnung. Name the molecule rather than the class, because the schedule lists forty two individual substances and a class description does not identify any of them. For flunitrazepam bring the special narcotic prescription form required by PV §10(3). The psychotrope placements were read at the 18 September 2026 consolidation whose last list amendment is BGBl II 394/2024 of 19 December 2024, and the class prescription entry at the prescription regulation consolidation listing BGBl II 282/2025.

Austria, Psychotropenverordnung Annex 1 point 1 for flunitrazepam and point 2 for the forty one named members, with the prescription regulation's class entry for benzodiazepine medicines marked NR · the psychotrope instrument read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the prescription regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Benzodiazepines in Austria, full detail →

Buprenorphine

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex IV.2 carries the word Buprenorphin. IV.2 is a separate list from IV.1 and carries its own closing wording, which is why the annex number rather than the roman numeral alone is what identifies the placement. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Buprenorphine is an Annex IV.2 narcotic, so substitution treatment patients are inside the authorized purpose rule and diverted supply is not. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Buprenorphine is the substance in this table most likely to be travelling lawfully, because Austrian substitution treatment is an authorized medical purpose under the SMG and the Suchtgiftverordnung.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. Substitution treatment documentation matters here more than for any other row, and SMG §44a separately penalises the specified substitution documentation and information breach up to EUR 3,600. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.2, the entry Buprenorphin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex IV.2 was read as a list distinct from IV.1, with its own closing wording, and the substitution treatment provisions in the Suchtmittelgesetz including §44a were read with it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Buprenorphine in Austria, full detail →

Caffeine

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. Caffeine is not designated in the narcotics, psychotrope or NPS instruments; the EU food information regulation requires qualifying high caffeine drinks to carry a statement of high caffeine content not recommended for children or pregnant or breastfeeding women. Separate labelling rules apply to foods with caffeine added. That is the whole of the control the dossier establishes.
Consequences if caught: Capital exposure: none. What Austria exposes a person to here is a product and food law exposure. The SMG ladder begins with a designation this substance does not have, and no capital sentence exists in Austrian law. Caffeine has no SMG exposure of any kind, and the only obligations found are labelling obligations on the seller. Because the applicable rule is not a drug offence, the SMG threshold machinery in §28b and the diversion route in §35 have nothing to operate on here either. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Caffeine is not a Suchtmittel and needs no prescription, so nothing in the Austrian drug instruments applies to carrying it.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. Caffeine's only Austrian obligation found is a labelling one, and it falls on the seller rather than the carrier. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the EU food information regulation Annex III point 4 high caffeine statement, with the absence of any narcotics, psychotrope or NPS entry · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the food information regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32011R1169 · at that placement the reading also covered this: the labelling rules for foods with caffeine added were read alongside the beverage warning, and all three drug instruments returned nothing · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Caffeine in Austria, full detail →

Cannabis / THC

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex I.1.a carries Cannabis (Marihuana), and the exclusions written around it turn on a 0.3 per cent figure. Flowers, fruiting tops, resin and the stated extracts and preparations are controlled. The industrial hemp exclusion is not a general permission: it requires the listed registered varieties, and the 0.3 per cent condition has to hold before, during and after production, with a further restriction on economically recoverable abusable amounts. The separate seed and leaf exclusion applies only where those parts are not mixed with flower or fruiting tops. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. Cannabis is the row where the cultivation limb bites, because SMG §27(1) reaches the specified cultivation conduct as well as possession. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Austria has no traveller allowance for cannabis; a cannabis medicine is inside SMG §5(1) only as a dispensed narcotic medicine, and a hemp product is a different question answered by the 0.3 per cent conditions rather than by a prescription.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. Do not rely on a 0.3 per cent label, because that figure is a condition on a production process and not a retail permission. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.a, the entry Cannabis (Marihuana) and the 0.3 per cent hemp conditions, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · the hemp variety and 0.3 per cent conditions were read in the annex itself · at that placement the reading also covered this: the registered hemp variety conditions, the before, during and after production requirement, the economically recoverable abusable amount restriction and the separate seed and leaf exclusion were each read in the annex itself rather than summarised from the percentage · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Cannabis / THC in Austria, full detail →

Cathinone

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex V.1 prints Cathinon on its own. The related cathine sits in the psychotrope regulation instead, which is why the khat plant engages two instruments at once. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. Cathinone is an Annex V.1 narcotic, and the Supreme Court has held that harvested cathinone bearing plant material falls under the SMG restrictions without further extraction. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No medicinal product for cathinone is established by the route this row records, so the limb realistically in question is the scientific one, which runs on a licence rather than on a prescription.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. Cathinone is the narcotic and cathine is the psychotrope, and the two travel under different rules. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry Cathinon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the psychotrope instrument was searched in the same pass, which is how the companion alkaloid's separate placement in Annex 1 point 1 was established · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Cathinone in Austria, full detail →

CBD

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. Pure cannabidiol is not named in the narcotics or psychotrope lists; its open ring structure is neither a tetrahydrocannabinol positional isomer nor one of the specified closed ring NPS cannabinoid cores, and the EU novel food regulation permits only authorised novel foods on the Union list to be marketed on the conditions that list sets. That is three separate negative findings and one positive obligation. Cannabis extracts, medicinal products and novel food uses each require their own conditions, so a CBD product is not automatically lawful because the molecule is unlisted.
Consequences if caught: Capital exposure: none. This row sits outside the drug ladder altogether, so neither the life ceiling in SMG §28a(5) nor any lesser SMG tier arises, and Austria has abolished capital punishment. CBD carries no SMG tier on the molecule itself, while the extract it came from may carry one, which is why the source material matters more than the cannabidiol content. Enforcement therefore runs through the authority that polices that instrument rather than through a drug prosecution, and the offence elements are the instrument's own. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. CBD is not a Suchtmittel, so no drug travel rule applies to it; a CBD medicinal product would be answered by the medicines act instead.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. The extract a CBD product came from can be controlled even where the cannabidiol itself is not. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the absence of a cannabidiol entry in the narcotics and psychotrope lists, the NPS cannabinoid core definitions, and the EU novel food authorisation requirement · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the novel food regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32015R2283 · at that placement the reading also covered this: three separate negatives were established in one pass, no narcotics or psychotrope entry, no fit to the enumerated tetrahydrocannabinol isomers, and no fit to the specified closed ring cannabinoid cores · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

CBD in Austria, full detail →

Clonazepam

Legal status: This is a designated psychotrope in Austria, which is the lighter of the country's two drug designations. In the Psychotropenverordnung, Annex 1 point 2 carries Clonazepam. It sits in point 2 with the other benzodiazepines rather than in point 1, which holds flunitrazepam and its special prescription form requirement. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §30, §31 and §31a offences. The psychotrope model mirrors the narcotics one: SMG §3(1) requires convention listing in Schedules III or IV together with a ministerial designation, with §3(2) available for a national addition, and the Psychotropenverordnung supplies the annexes. Annex 1 reaches the salts and preparations of the substances it names. There is no general derivative or isomer extension in this instrument, so an unlisted designer analogue is not brought in by resemblance.
Consequences if caught: Capital exposure: none. Ten years is the maximum, under SMG §§31(3) and 31a(3) for the specified criminal association preparation and trafficking conduct. The life ceiling in the narcotics instrument is not available against a psychotrope, and Austria is not a capital jurisdiction. Clonazepam is a point 2 psychotrope, and the anticonvulsant use it is prescribed for does not change the tier, only whether the conduct was authorized. Section 31 covers preparation above the threshold with intent to put it into circulation at two years, rising to five years above fifteen times the threshold, and §31a covers trafficking at three years and then five. SMG §44(5) separately reaches the administrative contraventions it names with a fine of up to EUR 36,300, and the six week imprisonment there is expressly in default of payment rather than a routine additional term. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Clonazepam's point 2 placement is what makes SMG §30(3) available to a dispensed supply, and the threshold condition written into that subsection is the part a carrier has to satisfy.
Documentation: Carry the pharmacy labelled pack, the prescription and a letter naming patient, substance, dose and treatment period, and raise the Psychotropenverordnung travel certificate with the prescriber before departure. Clonazepam is prescribed for seizure control as often as for anxiety, and the indication should be legible on the documentation. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Clonazepam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: point 1 and point 2 of Annex 1 were read as separate lists, point 1 carrying the special prescription form requirement under PV §10(3) that point 2 does not · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Clonazepam in Austria, full detail →

Cocaine

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex I.1.b prints the German spelling Cocain and nothing more. Annex I.1.c then extends I.1.b to all preparations of the narcotics listed there, which is how base and cut powders are reached. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Cocaine is an Annex I.1.b narcotic, and because SMG §28b fixes the threshold on the pure active substance, a low purity gross weight is not what the tiers are measured against. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The source establishes cocaine's Annex I.1.b designation and does not establish any Austrian medicinal product for it, so a clinical supply cannot be asserted from this material; what can be said is that nothing carried privately satisfies the authorized purpose rule.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The German spelling in the Austrian list is Cocain, which matters when a customs officer is reading a label. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Cocain, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex I was read to its end at page 28, including the I.1.c clause extending I.1.b to all preparations, which is the clause that reaches base and cut material · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Cocaine in Austria, full detail →

Codeine

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex II carries Codein, and Annex III.1 sets its combination limits at not more than 100 mg of narcotic per single dose calculated as base, or 2.5 per cent in undivided preparations. Qualifying combination preparations move into the special treatment of Annex III.1. They do not thereby leave the narcotics instrument, and describing a codeine cough product as simply outside Austrian drug law is wrong. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. Codeine is the row where the dose arithmetic decides the tier, because a preparation inside the Annex III.1 limits and one outside them are treated differently. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Codeine is the traveller's most common encounter with this system, and the Annex III.1 special treatment is what a qualifying combination product relies on rather than any general allowance.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. A combination codeine product relies on the Annex III.1 dose and composition limits, so keep the packaging that states the per dose content. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex II, the entry Codein, with the Annex III.1 dose and composition limits, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex II was read to its end at page 29 and Annex III to its end at page 30, so that the dose and composition limits and the special treatment they trigger were read as written · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Codeine in Austria, full detail →

Crack Cocaine

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. Crack has no entry of its own; Annex I.1.b carries Cocain and Annex I.1.c extends that list to all preparations of the narcotics under I.1.b. Crack is cocaine in base form, so the preparation clause reaches it and no separate crack listing was ever needed. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. Crack is charged as cocaine, so its tier is decided by the pure cocaine content under SMG §28b and not by the appearance of the rock. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Crack is a form rather than a product, and no medicinal form of it is established anywhere in the material read, so the authorized purpose rule has nothing to attach to.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. Crack is documented as cocaine in Austrian law, because that is the entry it is reached through. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b read with the Annex I.1.c clause covering all preparations of the I.1.b narcotics, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the I.1.c preparations clause was read as the operative step, no separate entry for the base form existing anywhere in the annex · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Crack Cocaine in Austria, full detail →

Delta-8-THC

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex V.1 lists tetrahydrocannabinol and then enumerates the isomers 6a(10a), 6a(7), 7, 8, 9, 10 and 9(11) together with their stereochemical variants. The 8 isomer is written into that list expressly, so delta-8-THC is a narcotic by name and not by any analogue argument. The other enumerated isomers sit in V.1 with it, while delta-9-THC itself is placed in IV.1 and THCA in V.2. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Delta-8-THC is on the Suchtgift ladder because it is an enumerated isomer, which is a stronger footing than the structural NPS route that catches the unlisted cannabinoids. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian delta-8-THC medicine is established anywhere in the material read, and a hemp derived delta-8 product does not become a medicine by being sold as a supplement.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. The enumeration in Annex V.1 names the 8 isomer specifically, so a delta-8 product cannot be argued to be unlisted. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the tetrahydrocannabinol entry enumerating the 6a(10a), 6a(7), 7, 8, 9, 10 and 9(11) isomers, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the full enumeration of tetrahydrocannabinol isomers was read position by position, and the separate IV.1 placement of the delta-9 isomer and the V.2 placement of the acid were noted against it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Delta-8-THC in Austria, full detail →

Diazepam

Legal status: Austria controls this under the Psychotropenverordnung as a psychotropic substance. In the Psychotropenverordnung, Annex 1 point 2 carries Diazepam. Diazepam is a psychotrope in Austria and not a narcotic. It is not in the Suchtgiftverordnung, it carries no life ceiling, and any description that places it there is wrong. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the §30 offence that follows it. Designation here is delegated in the same way as for narcotics. SMG §3(1) sets the convention and regulation test, the Psychotropenverordnung answers it, and the offences sit in SMG §§30, 31 and 31a rather than in §§27 to 28a. The Psychotropenverordnung extends its Annex 1 names to salts and preparations, and it carries no equivalent blanket derivative or isomer clause, which is a narrower reach than the narcotics instrument has. Its analogous preparation exemption runs at 0.01 per cent.
Consequences if caught: Capital exposure: none. This substance tops out at ten years, under SMG §31(3) and §31a(3). The life ceiling in SMG §28a(5) belongs to the narcotics instrument, which this is not in, and Austrian law carries no death penalty. Diazepam is a point 2 psychotrope, and SMG §35(1) expressly extends its conditional diversion route to §30 offences as well as §27 ones, so a personal use case can be stepped back from altogether. The middle tiers are §31(1) at two years and §31(2) at five years for preparation, and §31a(1) at three years and §31a(2) at five years for trafficking, with the subsection (4) reductions of one, three and five years under the §27(5) conditions. The fine and the custodial term in the basic offences are alternatives, and confiscation under SMG §34 is a separate consequence from both. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. A dispensed diazepam course in a traveller's bag is the paradigm case that wording describes, and it is worth saying plainly what follows: such a supply is an ordinary psychotropic medicine in Austria, not a dangerous drug, and no part of the narcotics instrument or its life ceiling touches it.
Documentation: Carry the original dispensing packaging and the prescription, and obtain the psychotrope travel certificate whose fields the Psychotropenverordnung sets out at the end of its Annexes 2 and 3. A prescribed diazepam supply sits in the psychotrope system and not in the narcotics one, so the ten year figure and not the life figure is the relevant ceiling. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Diazepam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: the narcotics instrument was searched for this substance in the same pass and returned nothing, which is the finding that keeps it out of the life ceiling entirely · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Diazepam in Austria, full detail →

DMT

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex V.1 carries the three letters DMT. The same annex then extends itself to all preparations of the narcotics it names, which is how brews and infusions containing it are reached. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. DMT is an Annex V.1 narcotic, and the preparations clause means a liquid containing it is charged on the pure substance rather than the volume. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal listing for DMT is established in the material read, so the limb that could realistically apply is the scientific one, under its own licence.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. DMT control is what makes an ayahuasca brew controlled, so the two rows answer together. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry DMT, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the V.1 clause covering all preparations of the narcotics in that annex was read as the route onto liquid and plant material, since no brew is named anywhere · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

DMT in Austria, full detail →

DOM

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex V.1 carries both of its historical names, STP and DOM. Listing the older street name alongside the chemical abbreviation removes any argument that a sample sold as STP is a different substance. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. DOM is an Annex V.1 narcotic, so its exposure is the same Suchtgift scale that reaches the other listed phenethylamines. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Nothing in the material read establishes a DOM medicine, so no patient route can be asserted for it under either of its listed names.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. A sample sold as STP is the same listed entry as DOM. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry STP, DOM, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: both of the historical names printed on the entry were read, which is what forecloses an argument that material sold under the older one is a different substance · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

DOM in Austria, full detail →

DXM

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. Dextromethorphan is expressly excepted from the relevant morphinan narcotic entry in Annex I.1.b, and it is then listed in the prescription regulation marked RP with exception R51. Exception R51 releases combinations of up to 15 mg of dextromethorphan per dose where the other substances are not centrally acting antitussives or narcotic analgesics. The general homeopathic exceptions in §1(2) and (3) of that regulation have their own dilution conditions and do not apply to injection medicines under §1(4).
Consequences if caught: Capital exposure: none. The obligations here come from food, product or trade law, because no narcotics or psychotrope designation exists, so no SMG tier and no life ceiling attaches. Austria has no death penalty in any case. DXM is the row where an express exception inside the narcotics annex is what keeps the substance off the Suchtgift ladder altogether. The penalties belong to the instrument that applies, are set by it rather than by the SMG, and bind the seller at least as often as the person holding the product. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. DXM is the case where a low dose combination cough product falls under exception R51 while a bulk powder does not, so the product form decides the answer.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. Exception R51 is dose and composition specific, so keep the packaging that states the dextromethorphan content per dose. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the Annex I.1.b exception excluding dextromethorphan, with the prescription regulation entry marked RP and exception R51 · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the prescription regulation and its exception annex were read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · at that placement the reading also covered this: the express exception inside the narcotics entry and the exception annex to the prescription regulation were read together, and the homeopathic exceptions and their exclusion for injection medicines were read with them · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

DXM in Austria, full detail →

Ephedrine

Legal status: Not a designated drug in Austria, and controlled as a drug precursor instead. Ephedrine is a category 1 scheduled substance in Annex I to the intra EU drug precursors regulation, listed by name and by the CAS number 299-42-3, with the third country precursors regulation covering external trade. That is a licensing and trade control rather than a narcotics or psychotrope designation. Ephedrine medicines additionally follow the prescription regime and the applicable medicinal product exclusions. SMG §32 supplies the Austrian offences that sit on top of the EU licensing scheme, and they are drafted around an intent that the substance be used in the unlawful production of narcotics.
Consequences if caught: Capital exposure: none. The ceiling here is five years, under SMG §32(3), for producing, importing, exporting or supplying a precursor with the intent that it be used in the unlawful production of narcotics. That is the precursor route's own maximum, no life term attaches to it, and Austria has no death penalty. Ephedrine is the only row in this table answered by the precursor regime, and its ceiling comes from a different SMG section than every other controlled row here. Below that, §32(1) reaches one year for producing, carrying or transferring a precursor with that intent, and §32(2) reaches two years for acquisition or possession with the specified above threshold manufacturing intent. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because ephedrine carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Ephedrine medicines exist and follow the prescription regime, while the precursor controls bind operators and traders rather than patients.
Documentation: Carry the dispensing record for any ephedrine medicine, and understand that the precursor controls are addressed to operators and traders rather than to patients. Ephedrine is controlled as a precursor and as a medicine, and neither of those is a drug schedule placement. The EU precursor consolidations dated 14 August 2025 were read on 18 September 2026; a future 18 September 2026 version was displayed by EUR-Lex and was not applied.

Austria, Annex I category 1 of the intra EU drug precursors regulation, the ephedrine entry with CAS number 299-42-3, read with the third country precursors regulation, read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:02004R0273-20250814 and https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:02005R0111-20250814 · the Austrian offences are Suchtmittelgesetz §32 with the five year ceiling at §32(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · the prescription regulation was read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: both the intra EU and the third country precursor regulations were read, and the CAS number printed beside the name in the category 1 annex was used to fix identity · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Ephedrine in Austria, full detail →

Etizolam

Legal status: A psychotrope in Austrian law, placed in the Psychotropenverordnung and not in the narcotics instrument. In the Psychotropenverordnung, Annex 1 point 2 carries Etizolam. Etizolam is a thienodiazepine rather than a true benzodiazepine, and Austria has answered that by naming it individually rather than by relying on a class label. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §30 onwards. SMG §3(1) defines a psychotropic substance as one subjected to the §2(1) restrictions by the United Nations Convention on Psychotropic Substances, contained in Schedules III and IV of that convention, and designated as a psychotrope by ministerial regulation; §3(2) permits further national designations, and the Psychotropenverordnung is the regulation that carries the list. Annex 1 reaches the salts and preparations of the substances it names. There is no general derivative or isomer extension in this instrument, so an unlisted designer analogue is not brought in by resemblance.
Consequences if caught: Capital exposure: none. The psychotrope ladder ends at ten years, through SMG §31(3) and §31a(3) for the criminal association forms of preparation and trafficking, with no life term above it and no capital sentence in Austrian law at all. Etizolam is a point 2 psychotrope, which is why it reaches the same ceiling as diazepam despite being sold as a research chemical rather than as a medicine. Section 30(1) and §30(2) carry the possession tiers at one year and six months, and the §35 diversion route is expressly available for offences under §30 as well as under §27. SMG §31b requires the psychotrope threshold to be set on the pure active substance, exactly as §28b does for narcotics. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Nothing read for this row establishes an authorised Austrian etizolam medicine, and SMG §30(3) is written for medicines, so a research chemical supply is not shown to reach it.
Documentation: Carry the dispensed pack with the prescription and a prescriber's letter, and ask the prescriber about the travel certificate whose fields close Annexes 2 and 3 of the Psychotropenverordnung. Etizolam is individually named in the Austrian psychotrope list even though it is not a benzodiazepine. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Etizolam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: the thienodiazepine entries in point 2 were read alongside the true benzodiazepine entries, the instrument naming both individually rather than by family · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Etizolam in Austria, full detail →

Fentanyl

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex I.1.b prints Fentanyl on its own line. The analogues that share its name in the illicit market are not reached by that word alone; each has to be found in its own entry or through the SV §1(5) isomer rule. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Fentanyl is an Annex I.1.b narcotic, and its threshold under SMG §28b is calculated on the pure active substance, which is a very small figure for a compound of this potency. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Fentanyl is the row where an authorized medical purpose is most plausible in practice, and this source does not establish one: it records the Annex I.1.b designation and no Austrian medicinal product. The conditional rule is what can honestly be stated, that a narcotic medicine genuinely dispensed is inside SMG §5(1) and a supply without that standing is not.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. A fentanyl patch is a narcotic medicine, and Austria treats it as one at the border as well as at the pharmacy counter. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Fentanyl, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the surrounding Annex I.1.b opioid entries were read in the same pass, and no general analogue clause was found there, so each related compound depends on its own entry or on the isomer rule · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Fentanyl in Austria, full detail →

Gabapentin

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: the prescription regulation lists gabapentin in part 2 of its Annex A and marks it RP, meaning a prescription is required. The narcotics, psychotrope and new psychoactive substances sweep did not establish any separate drug designation for it. A prescription entry applies to medicines and not automatically to every use of a raw chemical. AMG §7 sets the authorisation requirements with their exceptions, and §59 provides that medicines may be supplied only through pharmacies except where §§57 and 58 or the following provisions say otherwise.
Consequences if caught: Capital exposure: none. The exposure here is a medicines exposure, because neither the narcotics nor the psychotrope instrument designates this substance, so no SMG tier ever starts and no life term is available. Austria has no death penalty either. Gabapentin is a prescription medicine and nothing more, so no narcotics or psychotrope tier reaches it at any quantity. The figures are fact specific. AMG §84(1) reaches EUR 25,000, or EUR 50,000 on repeat, for the offences it lists, while the separate §83(1) dispensing breaches reach EUR 7,500, or EUR 14,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Gabapentin is a prescription only medicine, so the question at a border is the prescription and the dispensing, not a drug schedule.
Documentation: Carry the labelled pack and the prescription that produced it, since the whole of the Austrian control here is a prescription requirement. Gabapentin carries no Austrian drug designation, only a prescription requirement. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the gabapentin entry marked RP, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the narcotics, psychotrope and NPS instruments were each searched in the same pass and none of them returned an entry, so the prescription marking is the whole of the control · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «GABAPENTIN» carrying the status code RP, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, prescription required. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Gabapentin in Austria, full detail →

GBL

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is Annex I of the NPS regulation's structural annexes: the narcotics instrument expressly excludes butyrolactone from its Annex IV.1 ester extension by footnote, and the new psychoactive substances regulation then names Butyro-1,4-lacton in its Annex I. GBL is therefore excluded from one instrument by name and included in another by name, which is a deliberate placement rather than a gap. Being on the NPS list means the offence is the NPSG §4 supply offence with its intent elements, not simple possession. The new psychoactive substances regime works by generic definition. NPSG §3(2) permits chemical substance classes to be defined, NPSV §1(1) takes in Annex I by name and Annex II by structure, and Annex III's illustrations are examples rather than an exhaustive set. NPSG §1 requires psychoactivity and synthetic manufacture, and §2 removes lawful medicinal channels and SMG controlled substances from scope, so the structural fit is necessary and not sufficient.
Consequences if caught: Capital exposure: none. Ten years under NPSG §4(2) is the top of this route, available only on the fatal or gravely injurious consequence limb, and neither a life sentence nor a capital one exists anywhere in the NPS Act or in Austrian law. GBL is the row where an express exclusion from the narcotics instrument is what fixes the ceiling, because without that footnote the GHB ester extension would have reached it. The base offence in NPSG §4(1) allows two years, and it is emphatically not a possession offence: it requires an intention to obtain an advantage, the production, import, export, transfer or procurement conduct, and the intent that the other person or a third party use the substance to achieve a psychoactive effect in the human body. Mere possession is absent from it. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. GBL has industrial uses rather than medicinal ones, and NPSG §5 allows confiscation unless the lawful purpose exception is satisfied.
Documentation: Carry the analysis rather than the label, since NPSG §4(1) reaches supply conduct with an advantage intent and it is the identification of the compound that puts it inside or outside the annex. GBL is excluded from the narcotics ester clause by an express footnote and named on the NPS list instead. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, the Annex IV.1 footnote excluding Butyro-1,4-lacton (GBL) and the NPS regulation Annex I entry Butyro-1,4-lacton, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · the excluding footnote was read in the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · at that placement the reading also covered this: the excluding footnote in the narcotics annex and the naming entry in the NPS Annex I were read together, the same compound being excluded by one instrument and included by the other · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

GBL in Austria, full detail →

GHB

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex IV.1 lists gamma-hydroxybutyric acid and writes its exception into the entry itself: preparations are excepted where they contain no other controlled substance, are not applied to the human or animal body, and hold no more than 1 per cent GHB. That 1 per cent figure is specific to GHB and is not the general Suchtgiftverordnung preparation exclusion, which runs at 0.001 per cent and requires exclusively diagnostic or analytical use. All three GHB conditions have to hold at once. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. GHB is the row where the exception is inside the entry, so the prosecution question is whether the preparation meets all three stated conditions rather than whether the substance is listed. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. A GHB medicine can exist inside the authorized purpose rule, and the 1 per cent exception is expressly unavailable to anything applied to a human or animal body, so it is not a consumer allowance.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. The 1 per cent GHB exception excludes anything applied to a human or animal body, which rules out every drinkable preparation. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the gamma-hydroxybutyric acid entry with its 1 per cent preparation exception, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the three conditions written into the entry were read together with the general preparation exclusion at 0.001 per cent, so that the wider and narrower exceptions were not confused · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

GHB in Austria, full detail →

Heroin

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. In the Suchtgiftverordnung, Annex I.1.b prints the pharmacological name Diacetylmorphin beside the street name Heroin. Listing both removes the argument that the substance in a wrap and the substance in the schedule are different things. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. Heroin is an Annex I.1.b narcotic, and its street purity is irrelevant to the tier because SMG §28b calculates on the pure active substance. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Diamorphine has authorized medical uses in some systems, but the entry read here supplies no Austrian traveller route, and nothing outside a dispensed authorized medicine sits inside SMG §5(1).
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The Austrian entry names diacetylmorphine, which is the name a medical document would use. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Diacetylmorphin, Heroin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the pharmacological and street names printed on the single entry were both read, and the I.1.c preparations clause was read with them · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Heroin in Austria, full detail →

Hydrocodone

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex I.1.b carries the German spelling Hydrocodon. It sits in the same list as morphine and oxycodone, with the Annex I.1.c preparations clause available to reach finished products. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Hydrocodone is an Annex I.1.b narcotic, so a combination analgesic containing it is measured on its hydrocodone content under SMG §28b. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. This row establishes hydrocodone's Annex I.1.b designation and no Austrian medicinal product, so no dispensed route can be asserted from it; the general position still holds, that a narcotic medicine genuinely dispensed is inside the authorized purpose rule and an imported private supply is not.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. Hydrocodone is a narcotic here and not an ordinary prescription analgesic. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Hydrocodon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the neighbouring morphinan entries in I.1.b were read in the same pass, including the express exclusion of the antitussive that sits among them · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Hydrocodone in Austria, full detail →

Ketamine

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 8 of the NPS regulation's structural annexes: ketamine is a prescription medicine marked NR, meaning prescription required with repeat dispensing prohibited, and synthetic ketamine outside lawful medicinal channels fits the arylcyclohexylamine core in Annex II group 8 through its chloro, keto and N-methyl substitutions. Ketamine is not in the Suchtgiftverordnung and not in the Psychotropenverordnung. It is a medicine on one side and an NPS on the other, and NPSG §2 is the provision that keeps the medicinal channel out of the NPS regime. Austria regulates new psychoactive substances by structure rather than by list alone. NPSG §1 additionally requires psychoactivity and synthetic manufacture, and §2 excludes lawful medicinal channels and anything already subject to the Suchtmittelgesetz, so the SMG is applied first and the NPS scope second. The twelve cannabinomimetic cores and the other group definitions are alternatives rather than a catch all, and the annex has to be read as written rather than as a general ban on novel compounds.
Consequences if caught: Capital exposure: none. The Austrian NPS Act tops out at ten years under NPSG §4(2), and only where the §4(1) offence has caused a death or serious injuries to a larger number of people. No life term sits above that, and the death penalty does not exist in Austria. Ketamine is the row where the lawful channel and the unlawful one sit in different instruments, so the same molecule is a medicine in a hospital and an NPS in a wrap. NPSG §4(1) carries two years and three separate elements: the advantage intent, the specified supply conduct, and the intent that another use the substance for psychoactive effect. Possession alone satisfies none of them, although NPSG §5 still permits confiscation without prosecuting any particular person. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. Ketamine is the substance in this table where the prescription answer is strongest: it is a genuine Austrian medicine, dispensed on a non repeat prescription, and NPSG §2 expressly keeps that channel outside the NPS regime.
Documentation: Carry the dispensing record and the prescription for any ketamine medicine, because that is a real Austrian medicinal channel and NPSG §2 is what keeps it outside the NPS regime. A ketamine prescription is marked for no repeat dispensing, so a single dispensing record is what exists to show. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, the veterinary and human prescription list entry for ketamine marked NR, with Annex II group 8's arylcyclohexylamine core, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · the prescription entry was read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · at that placement the reading also covered this: the human and veterinary prescription lists were both read, and the NPSG §2 exclusion of lawful medicinal channels was read as the provision that separates the two routes · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Ketamine in Austria, full detail →

Khat

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. The plant has no entry; Annex V.1 lists cathinone, the psychotrope regulation lists cathine, and the Supreme Court in 15Os21/15z held that harvested parts of khat shrubs containing cathinone and cathine are subject to the SMG restrictions. Separation from the living plant is enough on that reasoning, and no further extraction step is required. Khat is therefore the one row in this table where a court judgment rather than a list entry supplies the operative step. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. Khat is charged through its cathinone content on the narcotics ladder, with cathine adding a psychotrope limb, so two different ceilings can be in play for one bundle of leaves. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal or cultural exemption for khat appears anywhere in the instruments read, and the Supreme Court reasoning runs the other way.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. The judgment that matters here is OGH 15Os21/15z, and it treats harvested leaf as already within the SMG. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry Cathinon, with the Psychotropenverordnung Annex 1 point 1 entry Cathin and Supreme Court judgment 15Os21/15z, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · the Supreme Court judgment 15Os21/15z was read at https://www.ris.bka.gv.at/Dokumente/Justiz/JJT_20150316_OGH0002_0150OS00021_15Z0000_000/JJT_20150316_OGH0002_0150OS00021_15Z0000_000.html · at that placement the reading also covered this: the Supreme Court judgment was read in full alongside both alkaloid entries, and it is the judgment rather than either list that supplies the step from living plant to harvested material · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Khat in Austria, full detail →

Kratom

Legal status: Not a designated drug in Austria, and the reason is a finding rather than a silence. Natural kratom leaf has no narcotics or psychotrope designation, and it sits outside the NPS Act because that Act defines a substance as a synthetically manufactured chemical compound. Food marketing still requires the applicable novel food authorisation under the EU regulation. The isolated alkaloids are a different question: mitragynine and 7-hydroxymitragynine each have their own determination in this table, and both of those could not be settled.
Consequences if caught: Capital exposure: none. Austria reaches this row through product and consumer law rather than through the drug instruments, so the SMG ladder never starts and its life ceiling in §28a(5) has nothing to attach to, in a country that executes nobody. Kratom leaf carries no SMG tier, and the unresolved questions in this corpus attach to its isolated alkaloids rather than to the leaf. Because the applicable rule is not a drug offence, the SMG threshold machinery in §28b and the diversion route in §35 have nothing to operate on here either. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Kratom is not a Suchtmittel and has no prescription route, so a traveller's question about it is a food marketing question rather than a drug one.
Documentation: Carry nothing under the drug instruments, because none of them designates this substance. The leaf and the isolated alkaloids are answered separately, and the alkaloid rows are the unresolved ones. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.

Austria, the absence of any narcotics or psychotrope kratom entry, the NPSG synthetic manufacture definition, and the EU novel food authorisation requirement · the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the novel food regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32015R2283 · at that placement the reading also covered this: the leaf was distinguished from its isolated alkaloids in the same pass, and the two alkaloid rows in this table both remain unresolved · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Kratom in Austria, full detail →

Lorazepam

Legal status: Controlled in Austria as a psychotropic substance, not as a narcotic. In the Psychotropenverordnung, Annex 1 point 2 carries Lorazepam. Its close relative lormetazepam is listed separately in the same point, which shows the list works entry by entry and not by family. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §30 offence rather than in the schedule line. The psychotrope model mirrors the narcotics one: SMG §3(1) requires convention listing in Schedules III or IV together with a ministerial designation, with §3(2) available for a national addition, and the Psychotropenverordnung supplies the annexes. The Psychotropenverordnung extends its Annex 1 names to salts and preparations, and it carries no equivalent blanket derivative or isomer clause, which is a narrower reach than the narcotics instrument has. Its analogous preparation exemption runs at 0.01 per cent.
Consequences if caught: Capital exposure: none. The ceiling on this route is ten years, carried by SMG §31(3) for preparation above the threshold as a member of a criminal association and by SMG §31a(3) for trafficking in the same form. No life term reaches a psychotropic substance at any quantity, and the death penalty does not exist here. Lorazepam is a point 2 psychotrope, so even a large diverted quantity stays on the ten year psychotrope scale. SMG §30(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement of a psychotropic substance, and §30(2) halves that to six months for exclusively personal use. SMG §44(5) separately reaches the administrative contraventions it names with a fine of up to EUR 36,300, and the six week imprisonment there is expressly in default of payment rather than a routine additional term. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Lorazepam sits in point 2 alongside the separately listed lormetazepam, and a dispensed course of the substance actually named on the prescription is the case SMG §30(3) addresses.
Documentation: Carry the pharmacy labelled pack, the prescription and a letter naming patient, substance, dose and treatment period, and raise the Psychotropenverordnung travel certificate with the prescriber before departure. Lorazepam and lormetazepam are separate entries, so name the one actually dispensed. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Lorazepam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: the separately listed closely related member in the same point was read alongside this entry, which is what shows the list works name by name · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Lorazepam in Austria, full detail →

LSA (Morning Glory)

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 11 of the NPS regulation's structural annexes: synthetic ergine fits Annex II group 11 through its 9,10-didehydro-ergoline-8-carboxamide base structure and its amino nitrogen methyl substituent, while the NPS Act defines a substance as a synthetically manufactured chemical compound. Natural seed material is therefore outside the NPS definition, because the Act requires synthetic manufacture. LSA is also chemically distinct from lysergic acid, which is the compound that appears on the EU precursor list, so the precursor regime does not reach it either. NPSG §3(2) authorises the Minister to define chemical substance classes where that is better suited than naming individual substances, and NPSV §1(1) includes both Annex I's named substances and every substance encompassed by Annex II's chemical definitions, with §1(2) enumerating the permitted substituent structures and Annex III illustrating rather than exhausting the groups. A structural overlap does not create simultaneous narcotics and NPS liability: the Suchtmittelgesetz is applied first and this regime only reaches what the SMG does not.
Consequences if caught: Capital exposure: none. The maximum here is ten years under NPSG §4(2), for a §4(1) offence resulting in death or serious injuries to a larger number of people. The life ceiling in SMG §28a(5) belongs to the narcotics instrument, and capital punishment to no part of Austrian law. LSA divides by origin rather than by structure, so the same molecule can be inside the NPS offence when manufactured and outside it when it came from seeds. Two years is the base figure under NPSG §4(1), and the shorthand that an NPS ban makes possession an offence is simply not the offence Austria wrote. Section 5 nonetheless permits confiscation unless the lawful purpose exception is met, and §7 supplies customs seizure powers. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. LSA has no medicinal listing, and its natural source material is a plant question rather than a prescription question.
Documentation: Carry no assumption that an absent name means an unregulated substance, because the NPS annexes work by chemical definition as well as by list and Annex III's illustrations do not exhaust the groups. The origin of the material decides this row, because the Austrian NPS Act reaches synthetically manufactured compounds only. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 11's 9,10-didehydro-ergoline-8-carboxamide base structure with the NPSG definition of a substance as a synthetically manufactured chemical compound, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: the EU precursor annexes were checked for the related acid, which is listed there, and this compound was found to be chemically distinct from it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

LSA (Morning Glory) in Austria, full detail →

LSD

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex V.1 carries (+)-Lysergid together with the abbreviations LSD and LSD-25. The entry fixes the stereochemistry in the name itself, and SV §1(5) then reaches the remaining stereoisomers and the pharmacologically comparable positional isomers. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. LSD is an Annex V.1 narcotic, and because SMG §28b calculates on the pure active substance, a blotter's paper weight is not the figure the tiers use. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal authorisation for LSD is established in anything read for this row, so no dispensed pack can be asserted to exist.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. The Austrian entry is (+)-Lysergid, which is the name to look for in any list. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry (+)-Lysergid, LSD, LSD-25, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the stereochemistry written into the entry was read together with the isomer rule in SV §1(5), which reaches the remaining stereoisomers · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

LSD in Austria, full detail →

MDA

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex V.1 prints the international non proprietary name Tenamfetamin alongside MDA. A search for MDA alone would find it, but a search only for the systematic methylenedioxyamphetamine name would not, which is why the annex prints both. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. MDA is an Annex V.1 narcotic, separately listed from the MDMA entry, so a mixture of the two is not one substance for threshold purposes. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Nothing read here establishes an Austrian medicine under either Tenamfetamin or MDA, so the medical limb is not shown to be open to it.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The Austrian list calls it Tenamfetamin, a name most travellers will not recognise. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry Tenamfetamin, MDA, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the international non proprietary name and the abbreviation printed side by side were both read, a search on the systematic methylenedioxy name alone returning nothing · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

MDA in Austria, full detail →

MDMA

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex V.1 carries the four letters MDMA. Its separate listing from MDA and from methylone in the same instrument shows that Austria lists these compounds individually rather than as a methylenedioxy family. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. MDMA is an Annex V.1 narcotic, and a pressed tablet is charged on its pure MDMA content under SMG §28b rather than on the tablet mass. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No MDMA medicine is authorized in Austria on the instruments read, so nothing lawful can be dispensed to a traveller.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. MDMA content and not tablet weight is what Austrian law measures. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry MDMA, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the separate V.1 and IV.1 placements of the two closely related methylenedioxy compounds were read against this entry, which is how it was established that Austria lists them individually · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

MDMA in Austria, full detail →

MDPV

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. In the Suchtgiftverordnung, Annex IV.1 prints the systematic 3,4-Methylendioxypyrovaleron with the abbreviation MDPV. Its placement in IV.1 rather than in the V lists gives it the IV.1 closing clauses on salts, esters, ethers and preparations. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. MDPV is an Annex IV.1 narcotic, so it sits on the full Suchtgift ladder rather than on the NPS route that catches unlisted cathinones. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No medicinal listing for MDPV is established in the material read, so no dispensing channel can be asserted for it.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. MDPV is listed by its full methylenedioxypyrovalerone name in the Austrian instrument. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry 3,4-Methylendioxypyrovaleron, MDPV, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex IV.1's closing clauses were read as the applicable extension set, the compound sitting in that annex rather than in either V list · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

MDPV in Austria, full detail →

Memantine

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: memantine appears in part 2 of Annex A to the prescription regulation marked RP, a prescription requirement. No narcotic, psychotropic or NPS designation was found for it anywhere in the instruments read. A marking in that annex binds the product rather than the molecule in every context. The medicines act supplies the surrounding structure, with §7 on authorisation and its exceptions and §59 confining supply to pharmacies subject to its own carve outs.
Consequences if caught: Capital exposure: none. Austria answers this row through the medicines act rather than through the drug instruments, neither of which carries an entry, so the SMG ceilings including the life term in §28a(5) are simply not in play, in a country with no capital punishment. Memantine is a dementia medicine with a prescription requirement, and the SMG scale does not reach it in any tier. AMG §84(1) provides fines of up to EUR 25,000 and up to EUR 50,000 on repetition for its own list of offences, and §83(1) provides up to EUR 7,500 and up to EUR 14,000 on repetition for the dispensing breaches it names. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Memantine's RP marking is the whole of the control, so the question at a border is whether the supply was dispensed on prescription and not where it sits on a drug schedule.
Documentation: Carry the pharmacy documentation for the supply, which is what establishes that the medicines regime was complied with. Memantine carries no Austrian drug designation, only a prescription requirement, so the dispensing record is the whole of the answer. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the memantine entry marked RP, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the adamantane entry was read in the human list, and the NPS structural annex was checked for a matching core and returned none · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «MEMANTIN» carrying the status code RP, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, prescription required. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Memantine in Austria, full detail →

Mephedrone (4-MMC)

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex V.2 lists it under the chemical name 4-Methyl-Methcathinon and does not print the street name mephedrone at all. A search for the word mephedrone in the Austrian instrument returns nothing, and that absence proves nothing about its status. This row is the clearest demonstration of why an absent street name is not an exemption. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Mephedrone is an Annex V.2 narcotic under its chemical name, so the full Suchtgift scale applies however the powder was sold. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian mephedrone medicine is established here, and the substance's absence under its street name does not create a gap a traveller could use.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. The Austrian entry is 4-Methyl-Methcathinon, so searching for mephedrone in the list will mislead. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.2, the entry 4-Methyl-Methcathinon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: a search on the street name was run against the whole instrument and returned nothing, which is why the chemical name in the annex is the only route to the entry · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Mephedrone (4-MMC) in Austria, full detail →

Mescaline

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex V.1 carries the German spelling Mescalin. The annex then extends to all preparations of the narcotics it names, which is what brings mescaline bearing cactus material into the system. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. Mescaline is an Annex V.1 narcotic, and the preparations clause is what carries that control onto consumable plant material. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal route for mescaline is established in the material read, and neither a religious nor a therapeutic claim is among the four purposes SMG §5(1) lists in any case.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. Mescaline control is what answers the peyote row, and the two should be read together. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry Mescalin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the V.1 preparations clause was read as the route onto consumable plant material, no cactus being named anywhere in the instrument · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Mescaline in Austria, full detail →

Methadone

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex I.1.b prints Methadon. It shares that list with morphine and the other classical opioids, and the Annex I.1.c preparations clause reaches the dispensed solutions. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. Methadone is an Annex I.1.b narcotic, so a take home substitution dose that leaves the treatment programme is a narcotics matter and not a prescribing irregularity. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Substitution treatment is an authorized medical purpose the SMG recognises, and SMG §44a penalises the specified substitution treatment documentation and information breach, so where a methadone supply has genuinely been dispensed within such a programme it is inside the authorized purpose rule and a diverted dose is not.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. A substitution patient's documentation is the whole of the defence here, and SMG §44a penalises the specified documentation and information breach up to EUR 3,600. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Methadon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the Annex I.1.b list was read in full and the substitution treatment documentation offence in SMG §44a was read with it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Methadone in Austria, full detail →

Methamphetamine

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex IV.1 carries Methamphetamin. It sits in the same list as amphetamine, and the IV.1 salts and preparations clauses reach the hydrochloride and every mixture of it. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Methamphetamine is an Annex IV.1 narcotic, and its ephedrine precursor is controlled under an entirely separate EU regime rather than under this annex. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The instruments read supply no traveller route for methamphetamine and establish no Austrian medicinal product, so only the general rule applies: a narcotic medicine genuinely dispensed is inside SMG §5(1) and nothing else is.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. The precursor question and the finished substance question are answered by different instruments. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Methamphetamin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the EU precursor annexes were checked in the same pass and the precursor control was found to sit in an entirely separate instrument from this entry · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Methamphetamine in Austria, full detail →

Methaqualone (Quaaludes)

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex IV.1 prints Methaqualon. It is a quinazolinone rather than a barbiturate, and it is listed on its own account and not through any sedative class clause. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. Methaqualone is an Annex IV.1 narcotic, which places it above the barbiturates that sit in the psychotrope regulation. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. This row establishes methaqualone's narcotics designation and no medicinal product, so a prescription issued elsewhere is not shown to correspond to any authorized Austrian purpose.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. Methaqualone is a narcotic in Austria, not a psychotrope, which is a heavier placement than most old sedatives receive. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Methaqualon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the quinazolinone entry was read in IV.1 and the psychotrope instrument was searched for it separately, the sedatives of that era being split across the two lists · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Methaqualone (Quaaludes) in Austria, full detail →

Methylone

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. In the Suchtgiftverordnung, Annex IV.1 prints Methylon together with the descriptive beta-keto-MDMA. The second name states the structural relationship to MDMA expressly, and the two substances are still listed separately and in different annexes. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. Methylone is an Annex IV.1 narcotic while MDMA sits in V.1, so a mixture of them engages two annexes with different closing clauses. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicinal listing for methylone is established in the material read, so the scientific limb under licence is the only one that could be in question.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The Austrian entry gives beta-keto-MDMA as an alternative name, which is useful when a label does not say methylone. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Methylon, beta-keto-MDMA, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the descriptive alternative name printed on the entry was read, and the separate V.1 placement of the compound it describes was compared with this IV.1 placement · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Methylone in Austria, full detail →

Methylphenidate

Legal status: A Suchtgift in Austrian law, listed rather than inferred. In the Suchtgiftverordnung, Annex IV.1 carries Methylphenidat. Being in IV.1 rather than in the psychotrope regulation places a very widely prescribed medicine on the narcotics side of the Austrian split. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Methylphenidate is an Annex IV.1 narcotic, so a diverted supply is measured against the same thresholds as any other IV.1 substance. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Methylphenidate's placement in the narcotics instrument rather than the psychotrope one has a direct consequence for anyone carrying it: the non punishment route in SMG §30(3) reaches psychotropic medicines and is therefore closed to it, so a dispensed methylphenidate supply relies on the authorized purpose rule alone.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. A methylphenidate prescription is a narcotic prescription in Austria, which is a heavier document than its everyday use suggests. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Methylphenidat, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the psychotrope instrument was searched for this substance in the same pass and returned nothing, which is what fixes it on the narcotics side of the split · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Methylphenidate in Austria, full detail →

Modafinil

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: modafinil appears in part 2 of Annex A to the prescription regulation marked NR, which requires a prescription and additionally prohibits repeat dispensing. The NR marking is a tighter medicines control than RP, and it is still a medicines control rather than a drug designation. No narcotics, psychotrope or NPS listing was established. This is a medicines control rather than a drug designation, and the two are separate systems in Austria. The medicines act's §7 authorisation requirement and §59 pharmacy supply rule are what surround the prescription entry.
Consequences if caught: Capital exposure: none. What applies is the medicines regime alone. No narcotic and no psychotrope designation exists, so the SMG ladder never begins, no life ceiling attaches, and the death penalty does not exist in Austrian law. Modafinil carries the stricter of the two prescription markings and none of the SMG tiers, so the exposure is a medicines law exposure only. Those two offence lists are distinct, and neither is an automatic fine for holding a prescription substance. AMG §84(1) tops at EUR 25,000, or EUR 50,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Modafinil's NR marking means the lawful route is a single dispensing on prescription with repeat dispensing prohibited, and there is no schedule exemption to fall back on because there is no schedule.
Documentation: Carry the dispensing paperwork rather than relying on the packaging alone, because the control here sits in the medicines regime. Modafinil is marked for no repeat dispensing, so a single dispensing event is what the record will show. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the modafinil entry marked NR, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the distinction between the two prescription markings was read in the regulation's own definitions, the stricter one additionally prohibiting repeat dispensing · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «MODAFINIL» carrying the status code NR, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, wiederholte Abgabe verboten, prescription required and repeat dispensing forbidden. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Modafinil in Austria, full detail →

Morphine

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex I.1.b prints Morphin. Codeine is held in Annex II rather than here, so the two natural opiates are placed in different lists with different closing rules. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. Morphine is an Annex I.1.b narcotic, and the Annex I.1.c preparations clause reaches the oral solutions and slow release tablets made from it. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Morphine is the paradigm of what the authorized purpose rule was written to permit, and the material read establishes the designation rather than any particular Austrian product, so the honest statement is conditional: a narcotic medicine genuinely dispensed is inside SMG §5(1) and an undispensed supply is not.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. A palliative or pain management supply is the paradigm authorized medical purpose, and the paperwork is what demonstrates it. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Morphin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex I.1.b was read in full and the separate Annex II placement of the other principal natural opiate was noted, the two sitting in different lists with different closing rules · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Morphine in Austria, full detail →

MXE

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex IV.1 prints Methoxetamin with the abbreviation MXE. It is listed by name, so unlike ketamine it does not depend on the arylcyclohexylamine structural core in the NPS annex. The line the schedule prints is the name and nothing more, so it proves placement and carries no operative words of its own; the prohibition comes from SMG §5(1), which confines every Suchtmittel to medical, dental, veterinary and scientific purposes, and the offences from SMG §27 onwards. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. MXE is an Annex IV.1 narcotic while ketamine is not listed there at all, so two closely related dissociatives carry different ceilings in Austria. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No medicinal use for MXE is established anywhere in the Austrian instruments read, unlike the ketamine it resembles, whose prescription entry this source does record.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. MXE and ketamine are answered by different instruments in Austria despite their similarity. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Methoxetamin, MXE, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the prescription regulation and the NPS structural annex were both checked for the related dissociative, whose treatment differs from this named entry's · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

MXE in Austria, full detail →

Nicotine

Legal status: Not a designated drug in Austria, and regulated as a consumer product instead. Nicotine is governed by the tobacco and non smokers protection act, whose §10h(7) caps tobacco free nicotine products at 1.6 grams total mass per consumption unit and 16.6 milligrams of nicotine per gram, while the prescription regulation's exception R72 releases nicotine medicines intended for smoking cessation. The version checked includes the 2026 amendment operative from 20 August 2026 under §18(18), with conditional wholesale deadlines of 31 December 2026 and consumer sell through to 30 June 2027 for qualifying earlier stock. Disposable electronic cigarettes have their own 31 August 2026 wholesale and 31 December 2026 retail deadlines. Those are transitional exceptions, not a suspension of the amended law.
Consequences if caught: Capital exposure: none. The ceiling on this row is a fine rather than a prison term. TNRSG §14(1) provides up to EUR 7,500, or up to EUR 15,000 on repetition, for the product, distance sale, youth sale and related violations it lists, and §§14(4) to 14(6) address premises duties, smoking and the playground prohibition with their own amounts. No SMG custodial tier reaches this row and Austria has no death penalty. Nicotine carries no SMG ceiling at all; its exposure is the tobacco act's own fine structure. Nothing in the tobacco regime turns on the SMG thresholds or on its diversion route, because it is not a drug offence at all. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Nicotine is not a Suchtmittel, and the only prescription question it raises is exception R72, which releases smoking cessation products from the prescription requirement.
Documentation: Carry nothing under the drug instruments for this, because no narcotics, psychotrope or NPS designation exists. A smoking cessation product relies on exception R72, and a tobacco free nicotine product has to meet the 1.6 gram and 16.6 milligram limits. The tobacco act was read on 18 September 2026 at the version including BGBl I 68/2026, operative from 20 August 2026 under §18(18).

Austria, the tobacco and non smokers protection act §10h(7) limits and §18(18) commencement, with the prescription regulation exception R72 for smoking cessation, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010907 · the prescription regulation exception was read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 and the medicines act at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the version applied includes BGBl I 68/2026 operative from 20 August 2026 · at that placement the reading also covered this: the transitional wholesale and retail deadlines and the separate disposable electronic cigarette deadlines were read in the commencement provision rather than inferred from the amendment date · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Nicotine in Austria, full detail →

Nimetazepam

Legal status: This is a designated psychotrope in Austria, which is the lighter of the country's two drug designations. In the Psychotropenverordnung, Annex 1 point 2 carries Nimetazepam. It is listed on the same footing as the therapeutic benzodiazepines even though it has no Austrian market, which shows the list is a control list rather than a formulary. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §30, §31 and §31a offences. Designation here is delegated in the same way as for narcotics. SMG §3(1) sets the convention and regulation test, the Psychotropenverordnung answers it, and the offences sit in SMG §§30, 31 and 31a rather than in §§27 to 28a. Annex 1 reaches the salts and preparations of the substances it names. There is no general derivative or isomer extension in this instrument, so an unlisted designer analogue is not brought in by resemblance.
Consequences if caught: Capital exposure: none. Ten years is the maximum, under SMG §§31(3) and 31a(3) for the specified criminal association preparation and trafficking conduct. The life ceiling in the narcotics instrument is not available against a psychotrope, and Austria is not a capital jurisdiction. Nimetazepam is a point 2 psychotrope, and its absence from Austrian pharmacies does not move it to a different tier. Section 31 covers preparation above the threshold with intent to put it into circulation at two years, rising to five years above fifteen times the threshold, and §31a covers trafficking at three years and then five. The fine and the custodial term in the basic offences are alternatives, and confiscation under SMG §34 is a separate consequence from both. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Nothing read here establishes an authorised Austrian nimetazepam medicine, so a foreign supply is not shown to be a medicine within the SMG §30(3) exception, which turns on the item being one.
Documentation: Carry the original dispensing packaging and the prescription, and obtain the psychotrope travel certificate whose fields the Psychotropenverordnung sets out at the end of its Annexes 2 and 3. A nimetazepam supply obtained abroad does not become an Austrian medicine by crossing the border. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Nimetazepam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: the prescription regulation was searched for this substance in the same pass and returned nothing, the psychotrope list being a control list rather than a formulary · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Nimetazepam in Austria, full detail →

Nitrous Oxide

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: nitrous oxide is in part 2 of Annex A to the prescription regulation marked NR, requiring a prescription and prohibiting repeat dispensing, and non medicinal products fall to product and food compliance. The molecule is absent from the narcotics and psychotrope lists, and it misses the NPS structural cores, which are organic ring and chain definitions that an inorganic gas cannot satisfy. A marking in that annex binds the product rather than the molecule in every context. The medicines act supplies the surrounding structure, with §7 on authorisation and its exceptions and §59 confining supply to pharmacies subject to its own carve outs.
Consequences if caught: Capital exposure: none. Austria answers this row through the medicines act rather than through the drug instruments, neither of which carries an entry, so the SMG ceilings including the life term in §28a(5) are simply not in play, in a country with no capital punishment. Nitrous oxide carries no SMG tier at all, and the Austrian control is a medicines control on the medicinal product plus product compliance on everything else. AMG §84(1) provides fines of up to EUR 25,000 and up to EUR 50,000 on repetition for its own list of offences, and §83(1) provides up to EUR 7,500 and up to EUR 14,000 on repetition for the dispensing breaches it names. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Nitrous oxide is a real medical gas, so a clinical supply runs on a non repeat prescription and a canister sold for consumer use does not.
Documentation: Carry the pharmacy documentation for the supply, which is what establishes that the medicines regime was complied with. Nitrous oxide is a medical gas here, and its non medicinal supply is answered by product and food rules. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the nitrous oxide entry marked NR, with the general product safety regulation, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · the general product safety regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32023R0988 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the NPS structural cores were checked against this molecule and are organic ring and chain definitions that an inorganic gas cannot satisfy · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «Distickstoffmonoxid» carrying the status code NR, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, wiederholte Abgabe verboten, prescription required and repeat dispensing forbidden. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Nitrous Oxide in Austria, full detail →

Opium

Legal status: This is a Suchtgift in Austria, which is the heavier of the country's two drug designations. In the Suchtgiftverordnung, Annex I.1.a carries the single word Opium. The SMG separately addresses the cultivation of opium poppy for obtaining narcotics, so the plant and the latex are dealt with by different provisions. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Life imprisonment is the top of this scale, reached through SMG §28a(5) alone, which pairs ten to twenty years with life for leading a larger connection of persons in §28a(1) conduct, in a system that has no death penalty. Opium is an Annex I.1.a narcotic, and SMG §27(1) reaches the specified cultivation conduct as well as possession, which matters for the poppy itself. Below it, §28a(1) allows up to five years for production, import, export or supply above the threshold, §28a(2) one to ten years for the commercial repeat, association and more than fifteen times cases, and §28a(4) one to fifteen years for the association recidivism, larger group and more than twenty five times cases. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian dispensing route for opium as such is established in the material read, and its individual alkaloids are listed separately, each answered in its own row.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The cultivation limb is live for this row in a way it is not for a synthetic substance. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.a, the entry Opium, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the Suchtmittelgesetz cultivation provisions were read alongside the entry, the plant and the latex being addressed by different provisions · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Opium in Austria, full detail →

Oxycodone

Legal status: Austria controls this as a Suchtgift under the Suchtmittelgesetz. In the Suchtgiftverordnung, Annex I.1.b prints Oxycodon. It sits alongside morphine and hydrocodone, and the Annex I.1.c preparations clause reaches the modified release tablets built from it. Reading the entry yields the placement only. No article, condition or operative provision sits inside it, and the working law is SMG §5(1) together with the §27, §28 and §28a offences. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. What this row exposes a person to runs as far as life imprisonment, carried by SMG §28a(5) and by nothing else, for leadership within a larger connection of people committing §28a(1) conduct. No Austrian offence is capital. Oxycodone is an Annex I.1.b narcotic, so a diverted prescription supply is measured on its pure oxycodone content under SMG §28b. The everyday tiers are §27(1) at one year or 360 day fines and §27(2) at six months for exclusively personal use, with §27(2a) reaching two years for the specified paid supply in a public transport vehicle. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. The route recorded here establishes oxycodone's Annex I.1.b designation and not any Austrian medicinal product, so a dispensed course cannot be asserted from this source, and only the conditional rule can be stated.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. An oxycodone course is narcotic medicine documentation, and a foreign label should name the active substance. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex I.1.b, the entry Oxycodon, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the modified release preparations were traced to the I.1.c clause rather than to any entry of their own, the annex naming active substances and not products · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Oxycodone in Austria, full detail →

PCP

Legal status: Designated a Suchtgift in Austria, and therefore on the narcotics rather than the psychotrope side of the split. In the Suchtgiftverordnung, Annex IV.1 carries Phencyclidin and not the abbreviation PCP. The NPS annex separately defines an arylcyclohexylamine core, but the SMG takes priority, so a named narcotic is answered on the narcotics side. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the offences that follow it. The route into control runs through SMG §2(1), which closes by requiring that a substance be subjected to the convention restrictions and designated as a narcotic by ministerial regulation, with SMG §2(3) available for a purely national addition. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The maximum is life, and SMG §28a(5) is the single route to it, for a leading role in a larger connection of persons carrying out §28a(1) conduct. Austria executes nobody, for this or for anything else. PCP is an Annex IV.1 narcotic, which is a heavier placement than the arylcyclohexylamine structural route that catches its unlisted relatives. Above simple possession, §28(1) reaches three years for holding more than the threshold with intent to put it into circulation, §28(2) five years above fifteen times that amount, and §28(3) one to ten years for membership of a criminal association. The word oder in the basic offences makes the fine and the custodial term alternatives rather than an addition, while the aggravated tiers above generally state imprisonment alone. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No Austrian medicine for phencyclidine is established in the material read, so the scientific limb under its own licence is the only one that could be in question.
Documentation: Carry documentation that ties this specific supply to a named patient and an authorized medical purpose: the dispensing pack, the prescription, and a letter from the prescriber covering substance, dose and duration. The Austrian entry is Phencyclidin, and a search for PCP in the list will not find it. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.1, the entry Phencyclidin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the arylcyclohexylamine core in the NPS structural annex was read against this named entry, and the priority rule in NPSG §2 was applied so that the named listing governs · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

PCP in Austria, full detail →

Peyote

Legal status: A Suchtgift in Austrian law, listed rather than inferred. The cactus is not named; Annex V.1 lists mescaline and extends itself to all preparations of the narcotics in that annex. Mescaline bearing preparations and harvested consumable material engage the mescaline control, applying the same harvested plant reasoning the Supreme Court used for khat. The living cactus is not itself named in the Suchtgiftverordnung and is not one of the three plants in the SMG cultivation offence, and the dossier records that this is reasoning applied by analogy rather than a peyote specific judgment. Designation works by delegation: SMG §2(1) makes a substance a Suchtgift only where the 1961 Single Convention subjects it to restrictions on production, possession, trade, import, export, handling or use and the Federal Minister for Health has designated it as a narcotic by regulation, and the Suchtgiftverordnung is the regulation that does so through the annexes its §1 assigns. The annex's own closing words reach the salts and preparations it names, and SV §1(5) adds stereoisomers and pharmacologically comparable positional isomers on top. The general preparation exclusion requires exclusively diagnostic or analytical use, no application to humans or animals, and no more than 0.001 per cent of each controlled substance, so it is not a low dose allowance.
Consequences if caught: Capital exposure: none. Austria's real ceiling on this substance is life imprisonment under SMG §28a(5), which offers ten to twenty years or life to a leader within a larger connection of people committing §28a(1) conduct, the death penalty having no place in Austrian law. Peyote is charged as mescaline, so the tier is set by the mescaline content of the material under SMG §28b and not by the number of buttons. SMG §27(3) and §27(4) allow up to three years for commercial commission and for the specified minor enablement or criminal association conditions, and §27(5) cuts the listed cases back to one year where dependence and self funding are made out. The threshold those tiers turn on is fixed by SMG §§28b and 31b on the pure active substance, so a gross mixed weight cannot be laid against it and the numeric figure changes with the compound. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. No religious or ceremonial exemption for peyote exists in any Austrian instrument read, and SMG §5(1) lists only medical, dental, veterinary and scientific purposes.
Documentation: Carry the dispensing pack, the prescription and a prescriber's letter naming the patient, the active substance, the dose and the treatment period, because the authorized purpose in SMG §5(1) has to be demonstrable at the moment it is questioned. A living plant and harvested consumable material are treated differently here, and only the latter clearly engages the mescaline control. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the mescaline entry read with the clause covering all preparations of the narcotics in that annex, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the three plant cultivation offence in the Suchtmittelgesetz was read and this plant is not among them, and the harvested plant reasoning is applied here by analogy from the khat judgment rather than from any judgment about this cactus · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Peyote in Austria, full detail →

Phenibut

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 2 of the NPS regulation's structural annexes: phenibut is not named in any Austrian list; Annex II group 2 covers any compound derivable from a phenethylamine base structure, and synthetic phenibut carries that core with a beta carboxymethyl substituent. The dossier records this as a structural interpretation supporting group 2 coverage rather than as a settled listing, and it remains subject to the Act's psychoactivity requirement and its exclusion of lawful medicines. Phenibut shares the group 2 definition with 2C-E, but the two arrive there by entirely different substitution patterns and the same wording answers them differently. The new psychoactive substances regime works by generic definition. NPSG §3(2) permits chemical substance classes to be defined, NPSV §1(1) takes in Annex I by name and Annex II by structure, and Annex III's illustrations are examples rather than an exhaustive set. NPSG §1 requires psychoactivity and synthetic manufacture, and §2 removes lawful medicinal channels and SMG controlled substances from scope, so the structural fit is necessary and not sufficient.
Consequences if caught: Capital exposure: none. NPSG §4(2) sets one to ten years where the §4(1) offence causes death or serious injury to a larger number of people, and that is the whole of the ceiling, with no life term and no capital sentence behind it. Phenibut is a nootropic sold openly in some markets, and in Austria it is reached only through a generic structural definition, so the derivation is the contested step rather than the conduct. The §4(1) offence sits at two years and reaches supply rather than holding. Section 4 specifies imprisonment with no cumulative fine, which is a different structure from the narcotics and psychotrope offences. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. Phenibut is not named in the narcotics list, the psychotrope list or the NPS Annex I under any spelling searched, so the only route to it is the structural one, and that is a contestable interpretation rather than a settled entry.
Documentation: Carry a written record of what the substance actually is, because the instrument that applies and the ceiling that follows both depend on the structural identification rather than on the name it was sold under. Phenibut is not named in any Austrian list and is reached by structural derivation only. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 2, the phenethylamine base structure definition, applied to synthetic phenibut with its beta carboxymethyl substituent, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: all three drug instruments were searched under each spelling of the name and returned nothing, so the structural derivation is the only available route · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Phenibut in Austria, full detail →

Pink Cocaine / Tusi

Legal status: Not applicable as a single status, and not because the Austrian instruments are silent. Pink cocaine is a street label rather than a substance: the source resolves it by constituents, recording that MDMA, 2C-B or cocaine makes the corresponding mixture a controlled preparation, that ketamine invokes the medicine and NPS branch instead, and that caffeine alone invokes food and product rules, with no fixed recipe assumed and no particular sample, concentration or undisclosed ingredient invented. Austrian narcotics control is delegated and closed, working entry by entry through the Suchtgiftverordnung annexes, so a powder sold under this name is whatever it analyses as, and the same name can produce different results from one sample to the next. The constituents reported under it are answered separately in this table, at the MDMA, 2C-B, cocaine, ketamine and caffeine rows, and those rows and not this one carry the schedule placements. No single terminal status can honestly be stated for the label itself.
Consequences if caught: Capital exposure: none. The custodial ceiling cannot be stated for the label at all, because it depends entirely on what the powder contains. A mixture holding MDMA or 2C-B is an Annex V.1 preparation and a mixture holding cocaine is an Annex I.1.b preparation, and either can in principle reach life imprisonment under SMG §28a(5), which provides ten to twenty years or life for leading a larger connection of people in §28a(1) conduct. A ketamine only psychoactive mixture leaves the narcotics instrument altogether and tops out at ten years under NPSG §4(2). A caffeine only powder carries no drug ceiling at all. SMG §28b compounds the problem in the other direction, because the threshold is taken on the pure active substance and a multi constituent powder has to be resolved into its parts before any tier can be applied. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. Whether the offence reaches this row at all is exactly what was not established, so they are recorded as Austria's published drug penalties and not as this row's exposure.
If prescribed / medical: Austria's traveller rule is SMG §5(1), and it cannot be applied to a label. The Act confines a Suchtmittel to medical, dental, veterinary and scientific purposes, which presupposes knowing which Suchtmittel is in question, and pink cocaine names no substance. Read the constituent rows instead: MDMA, 2C-B and cocaine are narcotics with no SMG §30(3) route, ketamine is a prescription medicine dispensed without repeat and kept out of the NPS regime by NPSG §2, and caffeine is not a Suchtmittel at all. No medical route exists for a mixture sold under this name in any case, because no such product is authorised.
Documentation: Carry nothing under this heading, because there is nothing to document: the label is not a substance and no Austrian instrument designates it. If the question is really about a constituent, use that constituent's row, and note that the same street name has produced samples with MDMA, 2C-B, cocaine, ketamine and caffeine in them. The constituent entries and the preparation clauses were read on 18 September 2026 at the narcotics consolidation whose last list amendment is BGBl II 180/2026, with the ketamine prescription entry read the same day.

Austria, Annex V.1 for MDMA and 2C-B, Annex I.1.b for cocaine, the clauses covering all preparations of the narcotics in those annexes, and the prescription regulation ketamine entry marked NR · the narcotics instrument read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the prescription regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 and the food information regulation at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32011R1169 · the offences are Suchtmittelgesetz §§27 to 28a with the life ceiling at §28a(5) and the NPS offence is NPSG §4, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 and https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Pink Cocaine / Tusi in Austria, full detail →

Poppers

Legal status: Not applicable as a single status, and not because the instruments are silent on nitrites. Poppers is a street label rather than a substance: the source records that amyl, isopropyl and cyclohexyl nitrites miss the NPS structural cores, that a recreational formulation is not automatically a medicine under the official interpretation, and that isobutyl nitrite additionally triggers chemical restrictions, with a mixture to be checked against each of its named constituents. The official poppers notice states that the former automatic functional medicine classification no longer follows the 2014 Court of Justice interpretation, while a medicinal presentation can still bring a product under the medicines act. Amyl nitrite holds a prescription medicine listing marked RP; isopropyl and cyclohexyl nitrites do not inherit it. Isobutyl nitrite is separately named in Appendix 2 to REACH Annex XVII, with entry 28 restricting supply to the general public at the applicable classification thresholds and subject to that entry's express exemptions. The constituents are therefore answered by three different instruments, and this row carries no single placement of its own.
Consequences if caught: Capital exposure: none. The exposure on this row is product and medicines exposure and it varies by constituent, because no nitrite carries a narcotics or psychotrope designation and no SMG tier arises at all. A medicinally presented product falls to the medicines act, where AMG §84(1) reaches EUR 25,000 or EUR 50,000 on repeat and §83(1) reaches EUR 7,500 or EUR 14,000 on repeat for the dispensing breaches it lists. An isobutyl nitrite product faces the REACH entry 28 supply restriction rather than a criminal drug charge. Everything else runs through the general product safety obligation on economic operators to place only safe products on the market. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. Whether the offence reaches this row at all is exactly what was not established, so they are recorded as Austria's published drug penalties and not as this row's exposure.
If prescribed / medical: Austria's traveller rule in SMG §5(1) does not reach this row at all, because no nitrite is a Suchtmittel and the authorized purpose rule governs Suchtmittel only. The prescription question exists for one constituent and not for the label: amyl nitrite has a medicine listing marked RP, so a dispensed amyl nitrite medicine is an ordinary prescription item. Isopropyl and cyclohexyl nitrites have no such listing and gain nothing from amyl nitrite's. A recreational bottle is not a medicine on the official interpretation, so a prescription is neither needed for it nor available.
Documentation: Carry the dispensing record if the item is genuinely an amyl nitrite medicine, and otherwise carry nothing under the drug instruments, because none of them designates a nitrite. Read the ingredient list, since isobutyl nitrite is restricted under REACH where the others are not, and a mixture has to be checked constituent by constituent. The official poppers interpretation, the prescription entry and the REACH entry were read on 18 September 2026, the chemical restriction text at its 1 September 2025 consolidation.

Austria, the prescription regulation amyl nitrite entry marked RP, the REACH Annex XVII Appendix 2 isobutyl nitrite entry with restriction entry 28, and the official poppers interpretation · the official interpretation read at https://www.basg.gv.at/marktbeobachtung/amtliche-nachrichten/detail/poppers, the prescription regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358, the medicines act at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441, the chemical restrictions at their 1 September 2025 consolidation at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:02006R1907-20250901 and the general product safety regulation at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32023R0988 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Poppers in Austria, full detail →

Pregabalin

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: pregabalin is in part 2 of Annex A to the prescription regulation marked RP. Despite its misuse profile in several other jurisdictions, the Austrian sweep found no narcotic, psychotrope or NPS designation for it. A prescription entry applies to medicines and not automatically to every use of a raw chemical. AMG §7 sets the authorisation requirements with their exceptions, and §59 provides that medicines may be supplied only through pharmacies except where §§57 and 58 or the following provisions say otherwise.
Consequences if caught: Capital exposure: none. This row's real ceiling is an administrative one under the medicines act, the drug instruments carrying no entry for the substance, no life term being available, and Austrian law carrying no death penalty. Pregabalin is controlled as a medicine in Austria and not as a drug, so none of the SMG ceilings applies to it however large the quantity. The figures are fact specific. AMG §84(1) reaches EUR 25,000, or EUR 50,000 on repeat, for the offences it lists, while the separate §83(1) dispensing breaches reach EUR 7,500, or EUR 14,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. A dispensed pregabalin course is an ordinary prescription medicine in Austria rather than a scheduled substance, and the RP marking is the whole of what has to be satisfied.
Documentation: Carry the dispensing record and the prescription, because the question at an Austrian border for this substance is a medicines question and not a drug schedule question. Pregabalin is a prescription medicine in Austria and is not on any Austrian drug schedule. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the pregabalin entry marked RP, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the drug instruments were searched for this substance despite its misuse profile elsewhere, and none of the three returned an entry · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «PREGABALIN» carrying the status code RP, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, prescription required. The veterinary part of the same regulation prints PREGABALIN with the tighter NR marking. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Pregabalin in Austria, full detail →

Psilocybin

Legal status: Controlled as a Suchtgift, placed there by regulation rather than by the statute itself. In the Suchtgiftverordnung, Annex V.1 prints Psilocybin. Psilocin and psilotin are listed separately in the same annex, and SMG §27(1)(3) carries a distinct conduct rule for psilocybin containing mushrooms. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §27 offence rather than in the schedule line. The statute does not carry the list. SMG §2(1) sets a two part test of convention restriction plus ministerial designation, SMG §2(3) allows a national addition where a substance has a comparable danger potential by reason of its effect and spread, and the Suchtgiftverordnung annexes supply the designation. Each annex is read on its own terms. The extension clauses differ between I.1.c, I.2, II, IV.1, V.1 and V.2, and SV §1(5) supplies the isomer rule for all of them without becoming a general analogue provision.
Consequences if caught: Capital exposure: none. Life imprisonment is where this ladder ends, in SMG §28a(5), for §28a(1) conduct committed while leading a larger connection of persons. Nothing capital exists anywhere in the Austrian code. Psilocybin is an Annex V.1 narcotic, and mushrooms containing it have their own conduct limb in SMG §27(1)(3), so the fungal material is dealt with expressly rather than by inference. SMG §28a(3) reduces the §28a(1) and §28a(2) ranges to three and five years under the §27(5) dependence and self funding conditions, and §28(4) applies the parallel reductions of one, three and five years to the §28 tiers. SMG §35(1) lets the prosecution step back provisionally for a probation period of one to two years where the act was exclusively for personal use and brought the accused no advantage, which is conditional diversion and not permission. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Psilocybin has no authorized Austrian medicine on the instruments read, so a clinical trial supply would run through the scientific limb of SMG §5(1) rather than through a prescription.
Documentation: Carry the original dispensing packaging together with the prescription and a signed prescriber's statement of the patient, the substance, the daily dose and the length of treatment, since a narcotic designation puts the burden of showing an authorized purpose on the person holding it. The mushroom limb sits in SMG §27(1)(3) and is separate from the substance listing. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex V.1, the entry Psilocybin, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: the separate psilocin and psilotin entries in the same annex and the distinct mushroom conduct limb in SMG §27(1)(3) were read alongside this entry · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Psilocybin in Austria, full detail →

Quetiapine

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: quetiapine is in part 2 of Annex A to the prescription regulation marked NR, so a prescription is required and repeat dispensing is prohibited. It is an antipsychotic rather than a controlled drug, and no narcotic, psychotrope or NPS listing was found for it. A marking in that annex binds the product rather than the molecule in every context. The medicines act supplies the surrounding structure, with §7 on authorisation and its exceptions and §59 confining supply to pharmacies subject to its own carve outs.
Consequences if caught: Capital exposure: none. The exposure here is a medicines exposure, because neither the narcotics nor the psychotrope instrument designates this substance, so no SMG tier ever starts and no life term is available. Austria has no death penalty either. Quetiapine is an antipsychotic under medicines control, and no part of the SMG penalty structure applies to it. AMG §84(1) provides fines of up to EUR 25,000 and up to EUR 50,000 on repetition for its own list of offences, and §83(1) provides up to EUR 7,500 and up to EUR 14,000 on repetition for the dispensing breaches it names. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. The dispensing record rather than any schedule position is what establishes a lawful quetiapine supply, and the NR marking means that record should show a single dispensing.
Documentation: Carry the labelled pack and the prescription that produced it, since the whole of the Austrian control here is a prescription requirement. Quetiapine is marked for no repeat dispensing, which is a medicines control and not a drug schedule. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the quetiapine entry marked NR, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the antipsychotic entry was read in the human list and no corresponding entry was found in any of the three drug instruments · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «QUETIAPIN» carrying the status code NR, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, wiederholte Abgabe verboten, prescription required and repeat dispensing forbidden. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Quetiapine in Austria, full detail →

Salvia divinorum

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is Annex I of the NPS regulation's structural annexes: the new psychoactive substances regulation names salvinorin A in its Annex I, and the Act defines a substance as a synthetically manufactured chemical compound. Natural Salvia divinorum leaf is therefore not criminalised by that listing, because the leaf is not synthetically manufactured. Synthetic salvinorin A is inside the NPS regime. The dossier notes that Annex I ends with salvinorin A, so nothing further was omitted from the end of that list. Austria regulates new psychoactive substances by structure rather than by list alone. NPSG §1 additionally requires psychoactivity and synthetic manufacture, and §2 excludes lawful medicinal channels and anything already subject to the Suchtmittelgesetz, so the SMG is applied first and the NPS scope second. The twelve cannabinomimetic cores and the other group definitions are alternatives rather than a catch all, and the annex has to be read as written rather than as a general ban on novel compounds.
Consequences if caught: Capital exposure: none. The ceiling is the one to ten years in NPSG §4(2), reached through the aggravated consequence limb of the §4(1) offence, in a system that has abolished the death penalty and attaches no life term to this Act. Salvia divinorum separates the plant from the isolated compound, and only the synthetically manufactured compound is inside the offence. The base offence in NPSG §4(1) allows two years, and it is emphatically not a possession offence: it requires an intention to obtain an advantage, the production, import, export, transfer or procurement conduct, and the intent that the other person or a third party use the substance to achieve a psychoactive effect in the human body. Mere possession is absent from it. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. No medicinal route exists for salvinorin A, and the plant is answered by food and product law rather than by prescription.
Documentation: Carry no prescription for this, because none is established anywhere in the material read: NPSG §2 only removes channels that already exist elsewhere. The leaf and synthetic salvinorin A are different legal objects in Austria. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, the NPS regulation Annex I entry Salvinorin A with the NPSG definition of a substance as a synthetically manufactured chemical compound, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: Annex I was read to its end, which the source records as terminating with this compound, so no closing catch all was silently omitted · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Salvia divinorum in Austria, full detail →

Scopolamine (Devil's Breath)

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: scopolamine appears in part 2 of Annex A to the prescription regulation marked RP. It is a tropane alkaloid with a long association with the plants it comes from, and it still carries no Austrian narcotic, psychotrope or NPS designation. This is a medicines control rather than a drug designation, and the two are separate systems in Austria. The medicines act's §7 authorisation requirement and §59 pharmacy supply rule are what surround the prescription entry.
Consequences if caught: Capital exposure: none. Austria answers this row through the medicines act rather than through the drug instruments, neither of which carries an entry, so the SMG ceilings including the life term in §28a(5) are simply not in play, in a country with no capital punishment. Scopolamine is a prescription medicine here, so the alarming reputation it carries in some reporting has no counterpart in the Austrian penalty structure. Those two offence lists are distinct, and neither is an automatic fine for holding a prescription substance. AMG §84(1) tops at EUR 25,000, or EUR 50,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria's traveller rule is the authorized purpose rule and there is no other. SMG §5(1) allows a Suchtmittel to be acquired, possessed, produced, processed, carried, imported, exported, offered, transferred or procured only for medical, dental, veterinary or scientific purposes and only as that Act provides, and professional licensing, medical dispensing and travel exemptions each remain subject to their own particular provisions rather than to any general allowance. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. An ordinary dispensed product is the lawful form of scopolamine, and its RP marking is the only Austrian requirement the material read attaches to it.
Documentation: Carry the pharmacy documentation for the supply, which is what establishes that the medicines regime was complied with. Scopolamine is a prescription medicine in Austria with no drug schedule attached. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex A part 2 of the prescription regulation, the scopolamine entry marked RP, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: the tropane alkaloid entry was read in the human list, and the plants it is obtained from were checked separately against the narcotics instrument · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «Scopolamin» carrying the status code RP, in A. HUMANARZNEIMITTEL, Teil 2. The regulation defines that code itself as Rezeptpflichtig, prescription required. The same part separately prints Butylscopolaminiumbromid as RP with the exemption code R 96, which Anhang I defines as ausgenommen bis 10 mg pro Dosis. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Scopolamine (Devil's Breath) in Austria, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Not applicable as a class status, and not because the annexes are empty. Synthetic cannabinoids is an open ended market label rather than a substance: the source maps each named member individually and records that no claim is made that everything sold under this label is automatically covered. Nineteen members are named in Suchtgiftverordnung Annex IV.1. That annex carries JWH-018 and AM-2201, with UR-144 and XLR-11, plus AB-CHMINACA and AB-FUBINACA, together with AB-PINACA and ADB-BUTINACA, then ADB-FUBINACA and CUMYL-PeGACLONE, alongside 5F-PB-22 and 5F-AMB-PINACA, next 5F-APINACA and 4F-MDMB-BINACA, followed by 5F-MDMB-PICA and 5F-MDMB-PINACA, and finally FUB-AMB with MDMB-CHMICA and MDMB-4en-PINACA. Three more sit in Annex V.2, namely ADB-CHMINACA, CUMYL-4CN-BINACA and 4F-MDMB-BICA, while DMHP and parahexyl sit in Annex V.1, delta-9-THC in Annex IV.1, the enumerated other THC isomers in Annex V.1 and THCA in Annex V.2. Everything else is reached, if at all, through the twelve separately defined cores in Annex II group 1 of the NPS regulation: indol-3-yl methanone, indol-3-yl methane, pyrrol-3-yl methanone, the two stated indene cores, 2-(3-hydroxycyclohexyl)phenol, indole-3-carboxylic acid derivatives, indazole-3-carboxamide, indazol-3-yl methanone, phenyl-ethyl isoindolone, oxo-benzimidazolin-N-carboxamide, tetrahydrobenzo[c]chromen-1-ol and hexahydrobenzo[c]chromen-1-ol. Those cores are alternatives and not an all cannabinoids catch all, and HHC, CBN and THCP carry their own rows because the cores answer them differently. No single terminal status can honestly be stated for the label itself.
Consequences if caught: Capital exposure: none. The custodial ceiling is member specific rather than class wide. A member named in Suchtgiftverordnung Annex IV.1, V.1 or V.2 is a narcotic and can in principle reach life imprisonment under SMG §28a(5), which provides ten to twenty years or life for a person leading a larger connection of people in §28a(1) conduct. A member reached only through one of the twelve NPS cores tops out at ten years under NPSG §4(2), and its base offence in §4(1) carries two years and is a supply offence rather than a possession offence. A compound that fits neither carries no drug ceiling at all until an instrument reaches it. Because the SMG is applied first, a structural overlap does not produce liability under both regimes, and the identification of the actual molecule is what decides between a two year offence and a life ceiling. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. Whether the offence reaches this row at all is exactly what was not established, so they are recorded as Austria's published drug penalties and not as this row's exposure.
If prescribed / medical: Austria's traveller rule is SMG §5(1) and it cannot be applied to a market label, because the Act confines a named Suchtmittel to medical, dental, veterinary and scientific purposes and this heading names none. No synthetic cannabinoid in either list has an Austrian medicinal authorisation, so no dispensed product exists to be carried under any of them. NPSG §2 keeps lawful medicinal channels outside the NPS regime, which is a carve out for authorised products rather than a route for a traveller. Delta-9-THC is the one related entry with a genuine medicinal dimension, and it is answered on the narcotics side rather than here.
Documentation: Carry nothing under this heading, since the label designates no substance and no product sold under it holds an Austrian authorisation. Identify the actual compound before asking the question, because the same phrase spans nineteen named Annex IV.1 narcotics, three in Annex V.2 and an open structural family in the NPS annex. The narcotics entries were read at the 18 September 2026 consolidation whose last list amendment is BGBl II 180/2026, and the twelve cores at the structural annex last amended by BGBl II 106/2024.

Austria, Annexes IV.1 and V.2 for the named cannabinoids including JWH-018 and ADB-CHMINACA, with the twelve cannabinomimetic cores in Annex II group 1 · the narcotics instrument read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the NPS structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf, the NPS Act at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605, the prescription regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 and the medicines act at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Synthetic Cannabinoids (K2 / Spice) in Austria, full detail →

THC-P

Legal status: Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is group 1(g) of the NPS regulation's structural annexes: THCP is reached through Annex II group 1(g), the tetrahydrobenzo[c]chromen-1-ol core, which it retains while carrying a heptyl side chain. That structural fit is what places it in the NPS regime rather than among the tetrahydrocannabinol positional isomers enumerated in the narcotics instrument. Natural cannabis extracts containing it require the separate extract analysis under the cannabis entry instead. NPSG §3(2) authorises the Minister to define chemical substance classes where that is better suited than naming individual substances, and NPSV §1(1) includes both Annex I's named substances and every substance encompassed by Annex II's chemical definitions, with §1(2) enumerating the permitted substituent structures and Annex III illustrating rather than exhausting the groups. A structural overlap does not create simultaneous narcotics and NPS liability: the Suchtmittelgesetz is applied first and this regime only reaches what the SMG does not.
Consequences if caught: Capital exposure: none. Ten years under NPSG §4(2) is the top of this route, available only on the fatal or gravely injurious consequence limb, and neither a life sentence nor a capital one exists anywhere in the NPS Act or in Austrian law. THCP is an NPS rather than an enumerated THC isomer, and that single distinction is the difference between a ten year ceiling and a life ceiling. NPSG §4(1) carries two years and three separate elements: the advantage intent, the specified supply conduct, and the intent that another use the substance for psychoactive effect. Possession alone satisfies none of them, although NPSG §5 still permits confiscation without prosecuting any particular person. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. THCP has no Austrian medicinal listing, and a hemp derived product containing it is a product law question rather than a prescription question.
Documentation: Carry the analysis rather than the label, since NPSG §4(1) reaches supply conduct with an advantage intent and it is the identification of the compound that puts it inside or outside the annex. THCP is not one of the enumerated tetrahydrocannabinol isomers, so it is answered by the NPS instrument. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Austria, Neue-Psychoaktive-Substanzen-Verordnung, Annex II group 1(g), the tetrahydrobenzo[c]chromen-1-ol core, applied to synthetic THCP with its heptyl side chain, the structural definitions read at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf and the illustrations at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261442/II_106_2024_Anlage_III.pdf, the regulation itself at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 · the offence and the definitions of substance and scope are Neue-Psychoaktive-Substanzen-Gesetz §§1 to 5, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007605 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the structural amendment applied is BGBl II 106/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/106 · at that placement the reading also covered this: the enumerated tetrahydrocannabinol isomers in the narcotics instrument were read against this structure, whose extended side chain is not among them · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

THC-P in Austria, full detail →

Tobacco

Legal status: Not a designated drug in Austria, and regulated as a consumer product instead. The tobacco and non smokers protection act prohibits selling tobacco products and the related products it defines to persons who have not completed their eighteenth year. Distance selling and sales to under eighteens are regulated by §§2a and 2b, and the act carries labelling, advertising and smoking restrictions alongside the age rule. It is a consumer product regime and not a narcotics or psychotrope designation.
Consequences if caught: Capital exposure: none. The ceiling on this row is a fine rather than a prison term. TNRSG §14(1) provides up to EUR 7,500, or up to EUR 15,000 on repetition, for the product, distance sale, youth sale and related violations it lists, and §§14(4) to 14(6) address premises duties, smoking and the playground prohibition with their own amounts. No SMG custodial tier reaches this row and Austria has no death penalty. Tobacco has no SMG exposure whatever, and the enforcement is the tobacco act's own fine structure aimed largely at sellers. Nothing in the tobacco regime turns on the SMG thresholds or on its diversion route, because it is not a drug offence at all. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. Tobacco is not a Suchtmittel and no prescription question arises for it at all.
Documentation: Carry nothing under the drug instruments for this, because no narcotics, psychotrope or NPS designation exists. The tobacco rules bind the seller far more than the carrier, so the obligations are mostly not the traveller's. The tobacco act was read on 18 September 2026 at the version including BGBl I 68/2026, operative from 20 August 2026 under §18(18).

Austria, the tobacco and non smokers protection act §2 prohibition on sales to persons under eighteen, with §§2a and 2b on distance selling, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010907 · the prescription regulation exception was read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 and the medicines act at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the version applied includes BGBl I 68/2026 operative from 20 August 2026 · at that placement the reading also covered this: the age, distance selling, labelling, advertising and smoking provisions were read as one regime, and the drug instruments were searched and returned nothing · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Tobacco in Austria, full detail →

Tramadol

Legal status: Controlled in Austria as a Suchtgift, a narcotic in the strict statutory sense. In the Suchtgiftverordnung, Annex IV.2 carries Tramadol and Annex III.2 names preparations of tramadol for its own special treatment. Every tramadol preparation named in Annex III.2 receives that annex's arrangements, which is a special regime and not a removal. Calling tramadol entirely outside Austrian narcotics law would be wrong. Austria designates by delegated regulation rather than by naming substances in the Act. SMG §2(1) requires both convention restriction and a ministerial designation, and the annexes of the Suchtgiftverordnung are that designation. SV §1(5) extends a listing to every stereoisomer and to those positional isomers whose structural similarity gives a comparable pharmacological effect, and it is not an open analogue clause; the annexes I.1.c, I.2, II, IV.1, V.1 and V.2 carry their own salts, esters, ethers and preparations extensions, which are read where they sit and not transplanted.
Consequences if caught: Capital exposure: none. The ceiling Austria does carry here is life imprisonment, and it sits at a single point: SMG §28a(5) provides ten to twenty years or life for a person who commits the §28a(1) conduct while acting in a leading role within a connection of a larger number of people. Capital punishment was abolished and plays no part. Tramadol is the row where a very ordinary analgesic sits inside the narcotics instrument, and the Annex III.2 special treatment is what keeps everyday prescribing workable. Beneath that the ladder is ordinary. SMG §27(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement, and §27(2) reduces that to six months or 360 day fines where the act is exclusively for personal use. Confiscation runs separately under SMG §34 by reference to StGB §26, and SMG §33 removes financial offence punishability for the same act on its stated conviction or diversion conditions, so a second fine is not simply added. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is a Suchtgift, the psychotrope non punishment route in SMG §30(3) is not available to it: that provision reaches medicines containing a psychotropic substance, and a narcotic is not one. The travel certificate fields that close Annexes 2 and 3 of the Psychotropenverordnung belong to the psychotrope system in the same way. Tramadol is prescribed constantly, and the Annex III.2 arrangements for its preparations are what a traveller with a dispensed course is relying on rather than any general allowance.
Documentation: Carry the labelled pharmacy pack and the paperwork that names you as the patient, states the active substance and dose, and gives the treatment period, because nothing about a narcotic is presumed lawful in Austria. Tramadol is inside the Austrian narcotics instrument even though its preparations have a special regime, so treat it as narcotic medicine documentation. The narcotics list was read at its 18 September 2026 consolidation, whose last listed amendment is BGBl II 180/2026 published 10 July 2026, which is a dated source horizon rather than a guarantee that no later instrument exists.

Austria, Suchtgiftverordnung Annex IV.2, the entry Tramadol, with the Annex III.2 preparations of tramadol, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053 · the designation power is Suchtmittelgesetz §2(1) and the offences are §§27, 28 and 28a with the life ceiling at §28a(5), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 180/2026 at https://www.ris.bka.gv.at/eli/bgbl/II/2026/180/20260710 · at that placement the reading also covered this: Annex III.2 was read to the end of its special treatment provisions at page 30, alongside the IV.2 entry itself · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Tramadol in Austria, full detail →

Xanax (Alprazolam)

Legal status: Controlled in Austria as a psychotropic substance, not as a narcotic. In the Psychotropenverordnung, Annex 1 point 2 carries Alprazolam. Its close analogues flualprazolam and clonazolam are separately named in the same point, so the instrument reaches each designer variant through an entry of its own rather than by extension from this one. That entry is a bare name. It establishes placement and nothing else, and the conduct rules live in SMG §5(1) and in the §30 offence rather than in the schedule line. SMG §3(1) defines a psychotropic substance as one subjected to the §2(1) restrictions by the United Nations Convention on Psychotropic Substances, contained in Schedules III and IV of that convention, and designated as a psychotrope by ministerial regulation; §3(2) permits further national designations, and the Psychotropenverordnung is the regulation that carries the list. The Psychotropenverordnung extends its Annex 1 names to salts and preparations, and it carries no equivalent blanket derivative or isomer clause, which is a narrower reach than the narcotics instrument has. Its analogous preparation exemption runs at 0.01 per cent.
Consequences if caught: Capital exposure: none. The ceiling on this route is ten years, carried by SMG §31(3) for preparation above the threshold as a member of a criminal association and by SMG §31a(3) for trafficking in the same form. No life term reaches a psychotropic substance at any quantity, and the death penalty does not exist here. Alprazolam is a point 2 psychotrope, so it never reaches the narcotics ceiling however much of it is involved. SMG §30(1) reaches one year or 360 day fines for unauthorized acquisition, possession, production, carriage, import, export, offering, transfer or procurement of a psychotropic substance, and §30(2) halves that to six months for exclusively personal use. SMG §31b requires the psychotrope threshold to be set on the pure active substance, exactly as §28b does for narcotics. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Alprazolam is a designated psychotrope with its salts and preparations included, and that placement is what puts a dispensed supply of it inside the wording of SMG §30(3) rather than outside it.
Documentation: Carry the dispensed pack with the prescription and a prescriber's letter, and ask the prescriber about the travel certificate whose fields close Annexes 2 and 3 of the Psychotropenverordnung. Alprazolam is a psychotrope and not a narcotic in Austria, which is the lighter of the two placements. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Alprazolam, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: Annex 1 was read to its end at page 14, where the salts and preparations extension and the 0.01 per cent exemption close it · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Xanax (Alprazolam) in Austria, full detail →

Xylazine

Legal status: Not a designated drug in Austria, and controlled instead as a prescription medicine. The placement is the Rezeptpflichtverordnung: xylazine sits in part 2 of Annex B to the prescription regulation, the veterinary list, marked RP. No narcotic or psychotrope entry and no matching NPS structural core was found for it. The veterinary listing authorises veterinary supply and does not authorise human recreational sale. A prescription entry applies to medicines and not automatically to every use of a raw chemical. AMG §7 sets the authorisation requirements with their exceptions, and §59 provides that medicines may be supplied only through pharmacies except where §§57 and 58 or the following provisions say otherwise.
Consequences if caught: Capital exposure: none. What applies is the medicines regime alone. No narcotic and no psychotrope designation exists, so the SMG ladder never begins, no life ceiling attaches, and the death penalty does not exist in Austrian law. Xylazine is the row where the only Austrian control is a veterinary prescription requirement, so the adulterant problem reported elsewhere has no drug schedule behind it here. The figures are fact specific. AMG §84(1) reaches EUR 25,000, or EUR 50,000 on repeat, for the offences it lists, while the separate §83(1) dispensing breaches reach EUR 7,500, or EUR 14,000 on repeat. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed / medical: There is one country level rule here and it is SMG §5(1): medical, dental, veterinary and scientific purposes are the only ones for which a Suchtmittel may be acquired, possessed, carried, imported or exported, and only on the Act's own terms. Travel exemptions, professional licensing and medical dispensing sit inside their own provisions, so no free standing traveller allowance exists above them. Because this substance carries no narcotic and no psychotrope designation, SMG §5(1) does not govern it and neither the psychotrope medicine exception nor the psychotrope travel certificate is in play. The medicines regime applies instead: AMG §7 sets the authorisation requirements with their exceptions and §59 confines the supply of medicines to pharmacies except where §§57 and 58 or the following provisions say otherwise. Xylazine is a veterinary medicine, so the lawful holder is a veterinary practice rather than a patient, and SMG §5(1)'s veterinary purpose is the limb that applies.
Documentation: Carry the dispensing paperwork rather than relying on the packaging alone, because the control here sits in the medicines regime. Xylazine sits on the veterinary list, so its lawful documentation is veterinary and not human. The prescription regulation was read on 18 September 2026 at the consolidation listing BGBl II 282/2025 as its latest amendment, through page 49 and including the exception and warning annexes.

Austria, Rezeptpflichtverordnung, Annex B part 2 of the prescription regulation, the veterinary xylazine entry marked RP, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010358 · the surrounding authorisation and pharmacy supply rules are Arzneimittelgesetz §§7 and 59 with the penalties at §§83(1) and 84(1), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010441 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · at that placement the reading also covered this: Annex B, the veterinary list, was read as a list separate from Annex A, and the veterinary entry the dossier records at the end of that reading is this one · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · the placement was confirmed against the regulation itself on 21 September 2026, read from the consolidated text whose own header reads Gesamte Rechtsvorschrift für Rezeptpflichtverordnung, Fassung vom 21.09.2026, 49 pages. The line printed is «XYLAZIN» carrying the status code RP, in the veterinary part, not the human part. The regulation defines that code itself as Rezeptpflichtig, prescription required. That is a reading of the instrument in this pass and no longer a citation carried forward · Updated September 21, 2026

Xylazine in Austria, full detail →

Zolpidem

Legal status: Austria controls this under the Psychotropenverordnung as a psychotropic substance. In the Psychotropenverordnung, Annex 1 point 2 carries Zolpidem. The dossier is explicit that zolpidem has its own entry and is not classified as a benzodiazepine, so the benzodiazepine class row does not answer for it. Nothing operative is written into that line. It is a listing, and the words that create liability are the authorized purpose rule in SMG §5(1) and the §30 offence that follows it. SMG §3(1) defines a psychotropic substance as one subjected to the §2(1) restrictions by the United Nations Convention on Psychotropic Substances, contained in Schedules III and IV of that convention, and designated as a psychotrope by ministerial regulation; §3(2) permits further national designations, and the Psychotropenverordnung is the regulation that carries the list. The Psychotropenverordnung extends its Annex 1 names to salts and preparations, and it carries no equivalent blanket derivative or isomer clause, which is a narrower reach than the narcotics instrument has. Its analogous preparation exemption runs at 0.01 per cent.
Consequences if caught: Capital exposure: none. This substance tops out at ten years, under SMG §31(3) and §31a(3). The life ceiling in SMG §28a(5) belongs to the narcotics instrument, which this is not in, and Austrian law carries no death penalty. Zolpidem is a point 2 psychotrope in its own right, so the benzodiazepine class label neither raises nor lowers where it sits. The middle tiers are §31(1) at two years and §31(2) at five years for preparation, and §31a(1) at three years and §31a(2) at five years for trafficking, with the subsection (4) reductions of one, three and five years under the §27(5) conditions. SMG §31b requires the psychotrope threshold to be set on the pure active substance, exactly as §28b does for narcotics. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. They describe the offences that this row's placement in the Austrian Suchtgift and psychotrope lists brings into play.
If prescribed / medical: Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this substance is a designated psychotrope, SMG §30(3) is available on its own terms. It removes punishment under §30(1) and §30(2) where a medicine containing a psychotropic substance, not exceeding the threshold, is acquired, possessed, carried, imported or exported for personal use or for the needs of an animal, or is offered, transferred or procured without the person drawing an advantage from it. It is not a blanket exception for psychotropic powder. The Psychotropenverordnung closes its Annexes 2 and 3 with travel certificate fields, which is where this system's documented route lives. Zolpidem's own point 2 entry, rather than any benzodiazepine class reasoning, is what brings a dispensed course of it within SMG §30(3).
Documentation: Carry the dispensed pack with the prescription and a prescriber's letter, and ask the prescriber about the travel certificate whose fields close Annexes 2 and 3 of the Psychotropenverordnung. Zolpidem is listed on its own account and is not a benzodiazepine in this instrument. The psychotrope list was read at its 18 September 2026 consolidation, whose last list amendment is BGBl II 394/2024 of 19 December 2024; the later BGBl II 10/2025 changed other provisions and not the list.

Austria, Psychotropenverordnung Annex 1 point 2, the entry Zolpidem, read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 · the designation power is Suchtmittelgesetz §3(1) and the offences are §§30, 31 and 31a with the ten year ceiling at §§31(3) and 31a(3), read at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011040 · RIS is the official publisher · its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions · the list amendment applied is BGBl II 394/2024 at https://www.ris.bka.gv.at/eli/bgbl/II/2024/394/20241219 · at that placement the reading also covered this: the imidazopyridine entry was read as a placement in its own right, the source recording expressly that it is not classified as a benzodiazepine · read as at 18 September 2026. · the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them · Updated September 21, 2026

Zolpidem in Austria, full detail →

Not individually verified

5 substances are not individually verified for Austria

For these the governing national drug law is cited, but we have not verified that the substance specifically is scheduled under it. Treat them as unanswered, not as legal. Confirm with Austria’s drug authority or your embassy.

Substance	What we found
5-MeO-DMT (Bufo / Toad)	Not confirmed. The Austrian designation of 5-MeO-DMT could not be settled, and the reason is a specific interpretive...
7-Hydroxymitragynine (7-OH)	Not confirmed. The designation of isolated or manufactured 7-hydroxymitragynine could not be settled in Austria, and...
Cannabinol	Not confirmed. A definitive NPS classification of pure cannabinol could not be settled, and the difficulty is a...
HHC	Not confirmed. HHC's current Austrian penal classification could not be reconciled, and the cause is a dated...
Mitragynine	Not confirmed. The status of manufactured mitragynine could not be conclusively settled, and the obstacle is the...

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index